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1. Introduction 
The main objective of this pilot proficiency test (PT) is to facilitate the production of reliable 
laboratory results of consistently good quality within the area of whole genome sequencing (WGS).  
Initially, a survey was launched to ensure that a future PT would serve the prober target audience as 
well as the bacterial pathogens of interest. In addition, the survey captured the information about 
what current quality markers being employed to ensure high quality sequencing data (7). The results 
of this survey were utilized to create the foundation of this pilot PT. 
Specifically, the PT will evaluate the consistency and robustness of Global Microbial Identifier 
(GMI) member’s and other’s ability to perform deoxyribonucleic acid (DNA) extraction, library 
preparation, the WGS, the assembly and phylogenetic analysis following different laboratory 
protocols, software tools, and sequence platforms for the reliability of submitted sequence data. 
This ensures harmonization and standardization in WGS and data analysis, with the aim to produce 
comparable data for the GMI initiative. A further objective is to assess and improve the process of 
uploading WGS data to databases such as National Center for Biotechnology Information (NCBI), 
European Bioinformatics Institute (EBI) and DNA Data Bank of Japan (DDBJ). To meet these 
objectives, the laboratory work and analyses performed for this PT should be performed using the 
methods routinely employed in the individual laboratories.  
The PT consists of two “Wet-lab” and one “Dry-lab” component targeting various bacterial 
pathogens. The Wet-lab components assess the laboratories ability to perform DNA preparation, 
sequencing procedures and, if laboratories routinely do so, the analysis of epidemiological markers; 
Multi Locus Sequence Typing (MLST) and antimicrobial resistance (AMR) genes. The Dry-lab 
component captures the laboratories analysis of a WGS dataset to distinguish between clonally 
related genomes.  
The results presented in this report were part of a pilot PT that was initiated as a ‘test run’ to allow 
for collection of experience with the purpose of adjusting documentation and/or the practical 
approach before the full roll-out of the PT, which is scheduled to be launched to a global audience 
in 2015. 
The main organizers of the GMI pilot PT are Technical University of Denmark (DTU), Kgs. 
Lyngby, Denmark in collaboration with U.S. Food and Drug Administration (US FDA), Silver 
Spring, Maryland, United States of America (USA). The Technical Advisory Group (TAG) for the 
GMI PT program consists of members and institutions of working group (WG) 4. The GMI PT 
organizers strive towards conducting the PT annually. 
Individual laboratory data are confidential and only known by the participating laboratory, the PT 
organizers (DTU Food, US FDA), and potential assisting members of the TAG.  All summary 
conclusions are made public. The tentative goal set by the GMI PT organizers and TAG aim 
towards having all participating laboratories performing WGS on single bacterial isolate cultures 
and supplied bacterial DNA allowing the TAG to set future thresholds for Quality Control (QC) as 
well as identifying all related genomes in the cluster analysis based on supplied data files. 
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2. Materials and Methods 
2.1 Participants 
A pre-notification (App. 1) to announce the GMI pilot proficiency test was distributed on the 17th 
June 2014 by e-mail to the 11 invited participants. The TAG agreed that participants of the pilot PT 
should all be current WG4 members to allow for collection of experience with the purpose of 
adjusting documentation or the practical approach before the full roll-out of the PT. Institutes 
signing up and submitting results were from Australia (1), Denmark (2), Germany (1), Spain (1), 
and USA (3). One country had intended to participate but reconsidered due to the political situation 
in the country at the time. Of the eight participants, seven delivered results for the Wet lab 
component, and another seven delivered results for the Dry lab component. For both components, 
some of the participating laboratories delivered only parts of the requested results and/or 
information. 
The results from the participating laboratories are presented and evaluated in this report; i.e. results 
from eight laboratories representing five countries and three continents are included. 
In addition to reporting results as requested in the PT protocol (Appendix 2), the participants were 
asked to capture and report any unfinished details that might still be in the PT material, e.g. in 
descriptions or in the handling/organization. This was conducted with the purpose of making the 
relevant adjustments before launching the full roll-out of the PT. 
  
2.2 Strains 
Two strains of Salmonella spp, Escherichia coli (E. coli), and Staphylococcus aureus (S. aureus) 
were selected for the Wet-lab of the GMI PT in 2014. The GMI14-001 was the S. Typhimurium 
strain LT2, the principal strain for cellular and molecular biology in Salmonella that was isolated in 
the 1940s (8). The second Salmonella strain; GMI14-002, was a S. Concord harbouring the 
antimicrobial resistance gene; blaSHV-12 gene and originally recovered from Ethiopian adoptees (3). 
The rationale for inclusion of the latter strain was our finding of the lack of amplification of the 
resistance gene on one specific sequencing platform. An O139 E. coli strain (GMI14-003) 
associated with edema disease in pigs (1) was intended to be included the panel. This strain and the 
corresponding purified DNA was, however, due to contamination issues, excluded before the 
shipment of the PT-material to the participants. In addition, an E. coli culture (GMI14-004) of 
unknown MLST obtained from a Danish pig isolated in 2011 was also included. The two S. aureus 
isolates included belonged to the clonal complexes (CC); CC30 (GMI14-005) and CC9 (GMI14-
006) and isolated in 1955 and 2011 from a pig and cattle in Denmark, respectively.  
Individual sets of the strains were lyophilized as KWIK STIKs by Microbiologics, St. Cloud, 
Minnesota, USA and the corresponding DNA were purified and pooled by DTU-Food prior to 
distribution in individual vials for each participant.  
To better be able to assess the differences in the sequences generated by the participants, each of the 
six strains in the Wet-lab component were sequenced on the PacBio to get a closed reference 
genome. This was done by creating 10KB template libraries using “10kb DNA Template Prep Kit 
1.0” from Pacific Biosciences, which were then sequenced using C2 chemistry on single-molecule 
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real-time (SMRT) cells with a 180min collection protocol. The data was then de novo assembled 
using the Hierarchical Genome Assembly Process (HGAP) within the Pacific Biosciences 
SMRTAnalysis software package. Polishing and finishing the genome were performed with custom 
python scripts, Quiver and Gepard, a dot plot tool to identify overlapping regions. 
 
2.3 Genomes 
A dataset consisting of raw sequence files (fastq files produced with Illumina MiSeq benchtop 
sequencer) were constructed for each of the three taxonomic groups represented in the Wet lab 
portion of the pilot-PT (E. coli, N = 22; S. aureus, N = 24; and S. Typhimurium, N = 20). 
Throughout this document this component of the pilot PT is referred to as the Dry lab. The samples 
within each dataset were chosen to generally represent the degree of variation that might be found 
in a typical outbreak/trace-back investigation within which there are a number of samples that differ 
by only a few Single Nucleotide Polymorphism’s (SNPs) with the remainder of the samples being 
quite genetically distinct (e.g., > 100 SNP differences).  
 
2.4 Distribution 
On 26 June 2014, for the Wet lab component of the PT, bacterial strains in agar stab cultures 
together with the corresponding purified and dried DNA and a welcome letter (App. 3) were 
dispatched in double pack containers (class UN 6.2) to the participating laboratories according to 
the International Air Transport Association (IATA) regulations as UN3373, biological substances 
Category B. On the same date, participants in the Dry lab component received the protocol in an 
email. An appendix to the protocol informed of how to access the sequence data to be analyzed. 
This data could be downloaded from a password protected ftp-server which was accessible for all 
participants.  
 
2.5 Procedure 
The protocols and all relevant information was sent by email and subsequently uploaded on the 
GMI website for direct download (http://www.globalmicrobialidentifier.org/Workgroups/About-
the-GMI-Proficiency-Test-Pilot-2014), thereby PT participants could access necessary information 
at any time.  
The protocol presented instructions as to the handling of the received bacterial cultures and DNA 
and participants were instructed on how to obtain access to the fastq datasets to be included in the 
Dry lab component.  
Participants were requested to capture information in relation to the questions presented in the 
SurveyMonkey, i.e. one for bacterial cultures and DNA, and one for the fastq datasets, for the 
components relevant to each participant’s level of participation.  
With the aim to improve future PT trials, participants were also encouraged to communicate 
directly with the PT-coordinator or to collect any questions or comments to the set-up or the 
documentation provided at the pilot PT. 
 8 
  
 
Deadline for submission of results was set for 15th August 2014, and after this date, participants 
who had not yet submitted results according to the level of their sign-up, were approached to 
confirm if they were planning on submitting results. By the end of August 2014, all relevant data 
was captured and the data analysis was instigated. This report summarizes the results and allows for 
ensures full anonymity for the participants, as only the PT-organizers has access to the individual 
results.  
 
2.5.1  SurveyMonkey, Wet lab 
Apart from three questions relating to the contact information of the participant, thirty-two 
questions were asked of those participating in the Wet lab component. The questions focused on the 
storage of bacterial cultures and DNA prior to analysis, the cultivation and DNA extraction 
procedure, the quality assurance parameters applied, details related to the sequencing and analysis 
of the obtained sequencing data (App. 2 (appendix 2 in the PT-protocol)).  
 
2.5.2  Sequencing, Wet lab  
The participants in the Wet lab analysis uploaded raw sequence files in fastq format. The reads were 
de novo assembled applying the standard assembly pipeline used by the web-services from Center 
for Genomic Epidemiology (CGE) https://cge.cbs.dtu.dk//services/all.php, except for the reads 
which were not trimmed prior to the assembly.  
For the raw reads, the following QC metrics were calculated: 
• Total numbers of reads (for paired-end reads, the total numbers of reads is calculated as the 
sum of reads in the two files)  
 
• Average read length (bp)  
 
• Number of reads that map to the total reference DNA (chromosome + any plasmids) using 
BWA (6)  
 
• Proportion of reads that map to total reference DNA  
 
• Number of reads that map to reference chromosome  
 
• Proportion of reads that map to reference chromosome out of all reads that map to total 
reference DNA  
 
• Number of reads that map to reference plasmid #1  
 
• Proportion of reads that map to reference plasmid #1 out of all reads that map to total reference 
DNA  
 
• Coverage, total reference DNA. The number of reads mapping to the total reference DNA 
multiplied with the average length of the reads divided by the total size of the reference genome  
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• Coverage, reference chromosome  
 
• Coverage, reference plasmid #1  
 
For the assemblies, the following QC parameters were calculated: 
• Total size of assembly (bp) (all contigs)  
 
• Total number of contigs  
 
• Number of contigs with a length above 200 bp  
 
• N50 (defined as the length of the shortest contig, in the set of largest contigs that represents at 
least 50% of the assembly)  
 
• NG50 (defined as the length of the shortest contig, in the set of largest contigs that represents at 
least 50% of the reference genome)  
 
• Coverage (The sum (lengths) of  “islands”) for total DNA calculated using COMPASS (2)  
 
• Validity for total DNA which reflects the alignable or validatable fraction of the assembled 
sequence (2) 
 
• Multiplicity for total DNA which reflects the ratio of the length of alignable assembled 
sequence to covered sequence of the reference (2)  
 
• Parsimony for total DNA which reflects how many bases of assembled sequence need to be 
inspected to find one base of real, validatable sequence (2)  
 
In addition to the calculation of the above QC metrics and parameters, participants were requested 
to provide the identification of the strains corresponding MLST and AMR genes to support the 
assessment of the sequence quality. Participates identified the MLSTs and AMR genes using the 
software of their choice. To assess the proficiency of the participants, the PT organizers used a 
command line version of the CGE MLST-Finder v.1.7 (5) and ResFinder  2.1 (9) (Threshold for 
%ID = 98% and HSP/Query length = 60%) including the CGE standard assembly pipeline on the 
participant’s raw reads to compare the results with those reported by the participants.  
Furthermore, strain specific reference routed phylogenetic SNP trees were created  (4) using the raw 
reads of both the culture and corresponding DNA submitted by each of the participants. This will 
support the assessment of the sequence quality of the participants.  
The phylogenetic SNP trees were created using the pipeline; CSI phylogeny v.1.0a available from 
CGE. The paired-end reads were mapped to the reference genome using Burrows-Wheeler Aligner 
(BWA) version 0.7.2. The depth at each mapped position was calculated using 
genomeCoverageBed, which is part of BEDTools version 2.16.2. SNPs were called using ‘mpileup’ 
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module in SAMTools version 0.1.18. SNPs were filtered out if the depth at the SNP position was 
not at least 10x or at least 10% of the average depth for the particular genome mapping. 
Subsequently, SNPs were selected when meeting the following criteria: 1) a minimum distance of 
15 bps between each SNP, 2) the mapping quality was more above 20, 4) the SNP quality was more 
than 20 and 5) all indels were excluded.  
The qualified SNPs from each genome were concatenated to a single alignment corresponding to 
position of the reference genome. The concatenated sequences were subjected to parsimony tree 
construction using PhyML with HKY85 substitution model and 100 bootstrap replicates. 
 
2.5.3  SurveyMonkey, Dry lab 
Twenty-one questions were asked of those participating in the Dry lab component, which focused 
on the preprocessing of fastq files that may occur within a lab in addition to the methods that were 
used to construct a cluster for outbreak and trace-back investigations (App. 2 (appendix 3 in the PT-
protocol)).  
 
2.5.4.  Sequence Matrix and Phylogeny, Dry lab 
The participants in the Dry lab component were asked to provide the results that they would 
typically produce as part of an investigation/study. In order to increase the number of laboratories 
willing to participate and get a more accurate picture of the diversity of methods being employed, 
we did not specify that any particular analysis pipeline or software had to be used. However, to 
provide some guidance as to what we were looking for we asked participants to upload, if they 
created them, a DNA/SNP matrix, a phylogeny, contigs, and distance matrix. The 21 questions that 
were part of the SurveyMonkey for the Dry lab compliment the files that were uploaded and 
provide additional information about the analyses performed by each participant (e.g., reference or 
reference-free SNP detection, MLST, etc. (App. 2 (appendix 3 in the PT-protocol)).  
For each SNP matrix we plotted the average pairwise distances among all samples against the size 
of the matrix to illustrate how the pipelines used by the different labs differed in the number of 
SNPs extracted (length of matrix) and the information content (average pairwise difference).  
Analyses of the topologies were complicated by the fact that participants differed in the number of 
samples included, which makes it difficult to conduct topological comparisons. Rather than drop 
tips to make the datasets be consistent in the samples they contained, we have not analyzed the 
topologies but suggest that for the future roll out the samples included in the matrix be only those 
samples provided (i.e., if a reference was used that was not part of the dataset, do not include that in 
the final results submitted).  
 
3. Results 
3.1 Participation 
A total of nine laboratories responded to the pre-notification and were enrolled in the GMI pilot PT. 
When the deadline for submitting results was reached, eight laboratories in five countries had 
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uploaded data. The following countries provided data for at least one of the PT components (Figure 
1): Australia, Denmark (2), Germany, Spain, and USA (3). Seven of the participating laboratories 
were from the public health sector and one laboratory represented food safety sector.  
 
3.2 Method description of the Wet lab component 
The laboratories received the reference material in the period from 24th of June to the 8th of July 
2014 and uploaded the results from the 29th of July to the 25th of August 2014.  
The bacterial cultures were stored at 4°C by 50% (n = 3) of the participants prior to the analysis. In 
addition, two participants (33%) stored the reference material at room temperature and one 
participant started the analysis on arrival of the organisms.  
Three participants (50%) stored the DNA in the time between reception and processing at room 
temperature whereas the remaining part of the participants stored the DNA at either -20°C, 4°C or 
started the analysis instantly. 
All six participants inoculated the bacterial cultures onto various types of blood agar and incubated 
the plates at 37°C between 16 to 24 hours. 
The Genomic DNA was extracted from both the Gram negative and positive strains using the 
Qiagen DNeasy Blood and Tissue kit according to the Gram negative and positive protocol by four 
participants (67%) whereas the two remaining participants used either the Invitrogen EasyDNA kit 
or the QIAamp DNA MiniKit. Five of the participants have modified the used Gram negative 
protocols by lysostaphin treatment prior to extraction and reduced enzyme incubation time from 3h 
to 1h. In contrast, four of the participants have modified the Gram positive protocol including a 
lysostaphin treatment step. 
DNA concentrations (ng/µl) of the bacterial cultures were determined prior to library preparation on 
a Qubit by four participants (67%) whereas the remaining two participants used either Nanodrop or 
Picogreen (Figure 2A). For the DNA received, five (83%) participants used the Qubit to measure 
the DNA concentration (ng/µl) prior to library preparation. One used the Picogreen (Figure 2B).  
Five (83%) participants measured the DNA concentration including the total amount of the five 
bacterial cultures whereas all six participants measured the DNA concentration of the provided 
DNA reference material (Table 1 and 2).  
For the Salmonella cultures, the DNA concentration ranged from 14.1 to 65.2 ng/µl and from 0.2 to 
128 ng/µl for the provided DNA (Table 1). For the E. coli culture the DNA concentration ranged 
from 9.64 to 110 ng/µl and from 0.2 to 80.7 ng/µl for the DNA. The DNA concentration ranged 
from 9.48 to 216 ng/µl and from 0.2 to 147 ng/µl for the S. aureus bacterial culture and DNA, 
respectively. One laboratory reported a concentration of 0.2 ng/µl for all DNA samples (Table 1). 
For the Salmonella culture, the total amount of DNA ranged from 1.2 to 6.5 µg and from 0.02 to 6.4 
µg for the provided DNA (Table 2). For the E. coli culture the total amount of DNA ranged from 
1.9 to 11 µg and from 0.02 to 7.2 µg for the total amount of DNA. The total amount of DNA ranged 
from 0.7 to 43.2 µg and from 0.02 to 7.9 µg for the S. aureus culture and DNA, respectively. One 
laboratory reported a concentration of 0.02 µg for all DNA samples (Table 2). 
 12 
  
 
Six and five participants responded to the method applied to measure the DNA quality (e.g. RIN, 
260/280 ratio and/or 260/230 ratio) prior to library preparation for bacterial cultures and DNA 
received. For bacterial cultures, three (50%) of the laboratories used the Nanodrop whereas one of 
the remaining three participants assessed the quality visually on a agarose gel. Two (33%) did not 
measure the DNA quality (Figure 3A). For the DNA received, one (20%) participant used the 
Nanodrop for measuring the DNA quality prior to library preparation and two (40%) either the 
Picogreen or visual assessment. One participant did not measure the DNA quality of the received 
DNA prior to library preparation (Figure 3B).  
Three and two participants reported the measurement of the DNA quality (e.g. RIN or 260/280 
ratio) for bacterial cultures and DNA received (Table 3). Among the three laboratories providing 
data of the DNA quality for the cultures, the level ranged from about 1.7 to 2.08. For the received 
DNA, the level between the three organisms was consistent around 2.0 (Table 3). 
Two participants reported the measurement of the DNA quality (260/230 ratio) for bacterial 
cultures and DNA received (Table 4). For the cultures and received DNA, the DNA quality was 
consistent around 0.5 to 2.0 (Table 4). 
Of the six participants, four used the Illumina Nextera XT DNA sample preparation kit FC-131-
1096 and one indicated using the Illumina NEB Next Ultra DNA Library prep kit for the 
preparation of the sample library before sequencing. One of the four participants using the Illumina 
Nextera XT DNA kit indicated using this in combination with the Nextera XT Index kit FC-131-
1002. In addition, one participant used the Ion Xpress Plus Fragment Library kit 4471248.  
The genomic DNA was prepared for pair-end sequencing by five (83%) participants whereas one 
prepared for single-end sequencing. The libraries were sequenced by five participants (83%) using 
an Illumina MiSeq platform and one used the Ion Torrent PGM platform (Figure 4). The read length 
of the sequences was set between 150 (n = 1), 200 (n = 1), 250 (n = 1) and up to 300 bp (n = 3). The 
reads were by five of the six participants trimmed before upload. Four participants indicated that if 
assembled by themselves, two would have used Velvet (https://www.ebi.ac.uk/~zerbino/velvet/), 
one would have used the Assemble pipeline (version 1.0) available from CGE and the last 
participant would have used the CLC Genomics Workbench 7. 
 
3.3 Sequencing, Wet lab – MLST, and antimicrobial resistance genes  
Five participants determined the MLST-type or alleles and detected AMR genes from both the 
received bacterial culture and corresponding DNA The four Miseq users also used the CGE 
“ResFinder” tool either solely or in combination with other online databases or in house scripts to 
detect the AMR genes. The Ion Torrent user utilized an in house tool; custom pseudomolecules 
(Table 5). 
Unfortunately, the WGS data revealed that the culture and the corresponding DNA of GMI14-004-
E.coli were contaminated. Up to approximately 15% of the sequence reads from this strain did not 
map to the reference DNA regardless of which participant has submitted the data why the strain has 
been analyzed with care. 
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For Salmonella; GMI14-001 the expected MLST was ST19 which were found in most cases. The 
expected results for participant 2 deviated for both the culture and the DNA with six alleles using 
the CGE reference MLST tool. The same was observed for participant 4 testing the culture using 
the CGE reference tool resulting in one deviating allele. In contrast, participant 9 seemed to have 
reported for the culture and the DNA sample using own tool the correct allele numbers but 
displaced in relation to the locos. The same displacement was also observed for the other PT strains 
by participant 9.  
The resistance gene; aac(6’)-1aa was reported by all participants for both the culture and DNA 
using own tools except for participant 3 who did not report any resistance genes. In contract, using 
the CGE reference tool; ResFinder, all participants found the related gene; aac(6’)-Iy (Table 6). 
The MLST 599 was expected in Salmonella strain; GMI14-002. This was reported by all 
participants except for participant 9 who for both the culture and DNA using an in-house tool 
reported a similar phenomenon as for GMI14-001. It is clear that this is a mistake and not related to 
the used tool, sequencing or reference materials as the allele number for aroC correspond to the 
MLST. 
Some variation among the participants, the reference material and tools used were observed for the 
detection of AMR genes in in Salmonella strain; GMI14-002. Concordance between reported genes 
detected by own tools and the CGE reference tool and between culture and DNA samples was 
observed for participant 1 except for reporting the presence of catA2 using own tool. In addition, 
using own tool on the DNA, an absence of aac(6’)-IIc was observed.  
Less concordance between reported AMR genes detected by own tools and the CGE reference tool 
was observed for participant 2. Participant 2 did not report using own tool in both samples the 
presence of dfrA18, ere(A), qnrB49, strB, tet(D), and aac(6’)-Iy in comparison to others. However, 
these AMR genes were observed using the CGE reference tool.  
Concordance was observed between culture and DNA and between tools for participant 4 except for 
the reported presence of catA2 and aac(6’)-IIb using own tool. These genes were infrequently 
reported by other participants using own tools.  
For participant 9, concordance was observed in most cases except for reporting the presence of 
catA2 and QnrB2 and absence of floR, QnrB49, and tet(A) by own tool compared to the CGE 
reference tool (Table 8).   
Unfortunately, no MLST has been assigned to E. coli strain; GMI14-004. However, the excepted 
allele code was 233, 2, 29, 167, 4, 16, and 4. This appeared to create some confusion as the majority 
of the participants reported this MLST incorrectly or did not report the alleles. It was evident that 
participant 9 had a problem reporting the MLST as the phenomenon mentioned above was 
consistent for also the E. coli samples. Participant 4 reported for both the culture and DNA samples 
using own tool all seven alleles identical but incorrect. This counted also for participant 3 but only 
for loci recA. 
The E. coli strain; GMI14-004 was a pan-susceptible strain harboring no antimicrobial resistance 
genes. Despite of this, the presence of qnrB49, strA, sul1, sul2, and aac(6’)-IIc were observed using 
the CGE reference tool for participant 2 in the culture. Additional AMR genes were both reported 
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and observed using own and the CGE reference tool on the DNA sample. This supports the above 
mentioned contamination as also the alleles for MLST were to some degree incorrect (Table 10). 
For S. aureus; GMI14-005 the expected MLST was ST433 which were found in most cases except 
for participant 2 and 9. Participant 9 also for S. aureus has the above mentioned problem reporting 
the MLST. For participant 2 all alleles were observed to be incorrect using the CGE reference tool 
on the culture but correct using own tool.  
The reported and observed AMR genes using own and CGE reference tool were identical for both 
the culture and DNA samples. The str2 was not reported by participant 1 but observed using the 
CGE reference tool. Interestingly, participant 2 reported the presence of blaZ, mecA(10), str2, and 
tet(38) using own tool in the culture and the DNA except for str2. In contrast, only the mecA(10) 
gene was observed using the reference CGE tool. Participant 3 reported the presence of the vga(A) 
and czrC genes for both the culture and the DNA samples which was not observed using the CGE 
reference tool. In contrast, the tet(38) and str2 were detected using the CGE reference tool. Using 
both tools also allowed for the detection of the mecA and blaZ genes. The AMR profile for 
participant 4 was identical for both the culture and DNA samples using both tools with the 
exception of additional observation of the tet(38) and str2. Similarly, consistency was observed for 
participant 9 where the additional observations were related to the reporting of fusA5 and aac(3)-Ik 
genes by own tool (Table 12). 
The MLST 9 was expected in S. aureus strain; GMI14-006. This was reported and observed by 
most of the participants for both sample types using both own and the CGE reference tool. 
However, participant 9 encountered the same problem also for this stain assigning the MLST as 
described previously using own tool. No problems were observed using the reference tool. In 
contrast, participant 2 reported the correct MLST for both the culture and DNA samples using own 
tool but failed when using the CGE reference tool. 
Participant 1, 4 and 9 all reported using own tool and observed when using the CGE reference tool 
the presence of tet(38) in both sample types. In addition, participant 4 reported using own tool the 
presence of the norA gene and participant 9 reported the fusA6 and blaZ genes. Participant 3 
reported using own tool for both sample types the presence of the fosB gene whereas the tet(38) 
gene was observed when using the CGE reference tool. The AMR profile for participant 2 seemed 
different compared to the other data reported. Participant 2 reported using own tool the presence of 
blaZ, mecA, and tet(38) genes in both the culture and DNA samples. This profile was similar to the 
expected profile of S. aureus strain; GMI14-005. Using the CGE reference tool on the culture 
provided the same profile as reported using own tool. However, using the reference tool on the 
DNA sample revealed the presence of strA and strB genes (Table 14). 
 
3.3 Sequencing, Wet lab – Quality markers 
Six participants submitted data related to the quality metrics and parameters from both the received 
bacterial culture and corresponding DNA. 
Initially, the quality markers were evaluated for potential contamination or a low performance by 
accessing the “total size of assembly”, “percentage of total size of assembly per total size of the 
reference DNA”, “N50” and “depth of coverage”. The quality markers for all PT strains produced 
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by participant 2 were all outliers with the exception of GMI14-002-Salmonella. The values for 
“percentage of total size of assembly per total size of the reference DNA” were all considerable 
above 100% indicating the submitted data being contaminated (Table 7, 11, 13, 15). In contrast, 
participant 5 obtained only 24.4% of total size of assembly per total size of the reference DNA 
indicating a poor sequencing of the DNA sample 4.  
The percentages of total size of assembly per total size of the reference DNA ranged from 93.6% 
(participant 5, culture GMI14-005-S.aureus (Table 13)) to 104.1% (participant 9, DNA GMI14-
004-E.coli (Table 11)) with strain medians of 99.1%, 98.3%, 102.4% (GMI14-004-E.coli), 97.9%, 
and 98.0% (Table 7, 11, 13, 15). As mentioned above, the samples of GMI14-004-E.coli were 15% 
contaminated but was included as an example of low contamination.  
The number of reads seemed to be consistent across the strains per participant (excluding poor and 
contaminated data from participant 2) ranging from 883248 (participant 3, GMI14-001-Salmonella) 
to 7243770 (participant 4, GMI14-005-S.aureus) with strain medians of 2334844, 1900294, 
2053210 (GMI14-004-E.coli), 2380956, 2532644 (strain 1-6) (Figure 6). 
The depth of coverage (x) also seemed to be consistent across the strains per participant (excluding 
poor and contaminated data from participant 2) with lower coverage of (GMI14-004-E.coli) 
(median of 59x ) compared to the S. aureus strains which in general provided a higher coverage; 
median of 151x and 140x (Figure 7). 
The total number of contigs seemed likewise to be quite consistent per strains and participants but 
with more variation across the PT strains with a higher number of contigs for (GMI14-004-E.coli) 
(median of 363) compared to the S. aureus strain GMI14-006-S.aureus which in general provided a 
lower number of contigs; median of 104 (Figure 8). 
The submitted data of N50 were highly similar per strain across participants i.e. from 40121 to 
40943 for strain GMI14-001-Salmonella (Table 7). However, more variation was observed across 
the “species” with medians for E.coli and Salmonella of 40872, 43232, and 44730, respectively 
compared to medians of S. aureus; 23816 and 22217, respectively (Figure 9, Table 7, 11, 13, 15). 
 
3.3 Sequencing, Wet lab – Phylogeny 
It was not possible to create phylogenetic trees for strain GMI14-001-Salmonella, GMI14-002-
Salmonella and GMI14-004-E.coli as no SNP differences between the participants’ submitted 
genome data were observed.  
In contrast, a total of 18244 SNPs difference was observed between culture and DNA samples of 
GMI14-005-S.aureus from participant 1. As no SNPs were observed among the other GMI14-005-
S.aureus genomes submitted by the other participants, suggesting that culture of GMI14-005-
S.aureus from participant 1 was contaminated (Figure 5).  
A minor SNP variation of eight SNPs was observed in the culture of GMI14-006-S.aureus 
submitted by participant 2 compared to the other genomes of strain 6 (Figure 6). This can be 
explained by the contamination described above. 
 
 16 
  
 
3.4 SurveyMonkey, Dry lab 
Eight laboratories participated in the Dry lab component of the pilot PT within which three datasets 
consisting of raw fastq files were provided. Participants were asked to carry out the analyses they 
would typically perform as part of an outbreak investigation or study. 
Quality filtering, assembly and reference genomes:  
Half the of the participants reported that they did quality filter raw reads; two laboratories 
reported using Trimmomatic (http://www.usadellab.org/cms/?page=trimmomatic), one used 
cutadapt (http://code.google.com/p/cutadapt/), and the fourth used NGS QC Toolkit 
(http://www.nipgr.res.in/ngsqctoolkit.html). 
Two of the participants also stated that they filtered contigs below a certain length (<200 and 
<1000); the other six labs did not report doing any filtering of contigs based on length. 
Six of the labs replied that they did calculate N50 two of which did so after filtering. Six labs 
also reported estimating coverage and the methods for doing so included using the expected 
genome size, as part of the pipeline used to quality filter and assembly (i.e., NGOPT), and as 
part of the mapping process.  
Two of the eight labs did not perform assemblies and for those that did, Velvet was the 
dominant assembler used (Table 16). 
All eight labs reported using a reference genome within their pipeline and interestingly not 
all labs chose the same reference (Table 17). 
Species verification and typing: 
Four labs reported not attempting to verify the species but those that did used Kraken 
(http://ccb.jhu.edu/software/kraken/), pathoscope 
(http://sourceforge.net/projects/pathoscope/), and Kmer Finder 
(https://cge.cbs.dtu.dk/services/KmerFinder/). Interestingly, labs reported being able to 
identify the species to which the fastq files belonged for sometimes only a specific group, 
which was likely an artifact of the setup in SurveyMonkey (i.e., only one answer was allowed 
and thus why one one participant replied “yes for all S. Typhimurium” but not the other 
groups). The SurveyMonkey has been edited to address this issue.. Also of note is that one 
sample of E. coli was found to be contaminated with Morganella morganii, which is correct. 
This sample has been removed from the dataset that will be provided during the full roll out. 
Four participants responded that they performed MLST. 
 
3.5 Sequence Matrix and Phylogeny, Dry lab 
All participants in the Dry lab stated that they used a SNP matrix for inferring phylogenies rather 
than, for example, a gene-based approach such as whole genome MLST. However, the survey was 
not adequately designed to extract the details of how the SNP matrix was constructed, which will be 
addressed in the full roll out of the PT. 
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Perhaps one of the more interesting results from the Dry lab component was that the number of 
sequences in the matrix/tips in the tree differed among the participants as some included a reference 
that was not part of the original dataset. This makes it extremely difficult to compare matrices and 
topologies and thus a subset of the potential comparative analyses were performed for the pilot. 
The matrices all differed in length with a median of 13196 bp (Table 18; Fig. 10). However, within 
E. coli the range was exceptionally large with one participant submitting a matrix that was 
approximately three times larger than the next biggest matrix.  
Although the participants produced different sized matrices, there is some consistency in the 
relative differences among samples. For example, within E. coli there are a number of samples that 
are consistently more different from other samples than the majority of samples (Fig. 11). This 
consistency in relative differences also suggests that the different methods may provide similar 
topologies and, thus, there may be congruence among conclusions based on the topology. However, 
we have not tested the differences in topologies due to different numbers of samples within the 
trees.  
All participants also stated that they inferred a phylogeny using a maximum-likelihood approach 
where the actual program used included PhyML (N = 2), RAxML (N = 3), GARLI (N =1), FastTree 
(N = 1), and Geneious (N = 1). Geneious software package includes a number of likelihood 
approaches so it is difficult to determine exactly which one was used. 
The participants differed as to how many clusters (2 to 6) were on the tree and the level of detail 
describing the process used to identify them (Table 19; Appendix 4).  
 
4. Discussion 
4.1 Overall 
The pilot PT was useful as it indicated the critical points where an improvement will be necessary 
for the full PT roll out. It provided some confusion and extra work to sort the submitted genomes by 
strains, source and participants mainly due to participants naming the sequence data in various 
ways. In the full PT roll out, the PT organizers will modify the protocol to ensure a proper way 
naming the sequence data to better distinguish data between the participants.  
In addition, the PT organizers observed some problems related to the submission to the ftp site 
which we will re-solve by submitting the Dry lab part to a ftp site but the Wet lab part via a CGE 
batch upload tool which will create an instant feedback of the quality marker results.  
Unfortunately, PT organizers was not aware that one of the E. coli strains included the PT was not 
designated a MLST at the time of this exercise. PT organizers will ensure to have all data collected 
prior to the full PT roll out. In addition, the fact that the PT strain; GMI14-004-E.coli was 15% 
contaminated prior to dispatching the samples to the participants was discovered too late by PT 
organizers. 
It was not possible to conduct the analysis as expected for the Dry-lab part mostly related to missing 
information. To adjust this, the PT organizers will modify the protocol, the survey to capture vital 
non-sequencing data and the method for analysis for the full PT roll out. 
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4.2 SurveyMonkey and Sequencing, Wet lab  
The majority of the submitted MLST data were correct and in line with the expected value. The 
results of MLST analysis revealed a systematic error for participant 9 either when submitting the 
data. The reported allele numbers were for all loci dislocated by one allele “downward” with the 
correct MLST reported for allele aroC using own tool. However, the MLST was correct for all PT 
strains when re-analysed using the reference method. The MLST results also revealed some 
deviations for participant 2 which compared to AMR genes and the quality markers showed that the 
whole genome sequencing at some point of stage for all PT strains except for GMI14-002-
Salmonella had been contaminated. A few other deviations were observed i.e. hisD in the culture of 
GMI14-001-Salmonella which deviated for participant 4 between using own tool and the CGE 
reference assembler. Interestingly, participant 4 also used the CGE reference assembler and MLST 
tool as “own tool” why it is suspected that the deviations might be a results of running the tools as 
the online stand-alone version compared to running the analysis by command line. Another example 
of deviations was observed for participant 3 testing the PT strain GMI14-004-E.coli for both sample 
types. Running the analysis using own tool resulted in an incorrect allele number; 99 for recA 
whereas a different incorrect allele number; 215 for recA was reported using the CGE reference 
tool. This might be a result of the assembler used which potentially could have resulted in truncated 
contigs. 
Most of the submitted AMR genes were in concordance with the expected results. However, some 
deviations were observed. All participants; expect for participant 3, despite of own tool used 
reported the AMR gene; aac(6')-Iaa for both sample types whereas the gene reported using the 
CGE reference tool was aac(6')-Iy. The reason for the discrepancy was related to a change in the 
CGE reference tool database; “the ResFinder” where the two genes were re-named. This affected all 
participants using the ResFinder tool.  
Participant 3 reported using an in-house AMR gene tool; “pseudomolecules” which potential could 
be the reason for different AMR profiles reported compared to the other profiles in concordance 
with the expected i.e. GMI14-002-Salmonella. Similarly, participant 2 also reported different AMR 
profiles which were not surprising taking the contamination into account. It could be speculated if 
the contamination in PT strain GMI14-004-E.coli could be a result of mixing with also GMI14-002-
Salmonella. The PT strain GMI14-004-E.coli was expected being pan-susceptible but reported by 
participant 2 harbouring a highly similar AMR profile as the PT strain; GMI14-002-Salmonella. 
The phylogenetic analysis revealed no SNP difference between the participants’ genomes for PT 
strains; GMI14-001-Salmonella, GMI14-002-Salmonella, and GMI14-004-E.coli. Only a few; eight 
SNPs were observed for the culture of GMI14-006-S.aureus submitted by participant 2. Eight SNPs 
from clonal strains is a bit more than expected in relation to spontaneous mutations why the 
discrepancy more likely was related to the mentioned contaminations. In contrast, a huge difference 
in number of SNPs was observed creating the phylogenetic tree of GMI14-005-S.aureus with 
18,244 SNPs between the culture and DNA submitted by participant 1. It was not possible to detect 
any other deviations e.g. for MLST, AMR genes and quality markers. 
One of the objectives for the GMI PT was to assess a range of quality markers enabling the 
organizers to propose / set quality control thresholds. However, this was not possible taken into 
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account the few participants in this pilot PT. Nonetheless, it was possible to detect contamination of 
the PT strains from participant 2 based on primarily; “Total size of assembly”, “Percentage of total 
size of assembly per total size of DNA”, “Total no. of contigs”, “No. of contigs > 200 bp”, and 
“N50”. N50 is one of the vital quality markers and good quality has been suggested to be around 
30,000 across all bacterial species. It was surprising to see that N50 seemed to be that species 
depended as all N50’s from all participants clustered per PT strains and species. By expanding the 
PT to a greater number of participants with a full roll out of a future PT, the PT organizers hope to 
be able to set some quality control thresholds ensuring reliable sequencing data for the future. 
 
4.3 SurveyMonkey and Phylogeny, Dry lab  
The survey of the Dry lab component highlighted the diversity of methods that exist to analyse and 
cluster based on whole genome sequence data. For example, not all labs quality filtered reads before 
performing down stream analyses and not all labs tested for contamination or verified species. 
There was some consistency in that each lab used a reference-based approach to identify variant 
sites but at the same time each lab often used a different reference.  
The participants also differed in what samples were included in the final matrix, which made it 
difficult to compare topologies. 
The results from the pilot PT also highlighted some deficiencies in the survey that inhibited our 
ability to adequately compare the methods of the different labs. In particular, no questions were 
posed regarding the software used to perform mapping and identify variant sites. Also, the question 
regarding how clusters were determined was vague and as a result the answers were difficult to 
interpret; perhaps that question should be removed.  
Below are some specific recommendations/comments for the full PT based on the results from the 
pilot: 
• Clearly state how sequences are to be named in the fasta file and subsequent tree 
• Instruct participants to only include samples that were supplied (e.g., if they chose a 
reference outside the provided samples do not include that reference in the SNP matrix or 
tree file) 
• If a reference-based approach was used ask the following: 
o What mapper was used 
o What software was used to identify variant sites 
• If a reference-based approach is used then they can ignore the questions about assemblies. 
Perhaps the survey could be setup to first ask if they use an assembly or reference based 
method and depending on the answer to that question the participant moves to a certain 
section were relevant questions surround each of those approaches can be found. 
• Should we specify the reference? This would remove our ability to determine the diversity 
of references chosen but in turn would allow us to focus more on how the different SNP 
methods call variant sites when working with the same reference. 
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5. Conclusions  
The pilot PT was a useful exercise as it allowed WG4 to identify critical points for improvement 
prior to the full roll-out. The Wet lab part worked as anticipated and provided interesting data 
identifying several sequencing deviations such as contaminations and poor sequencing.  
The PT indicated several quality markers which could be used and considered as future QC 
standards for assessing sequence quality. With the limited data submitted in the pilot PT it was, 
however, not possible to determine specific QC measures. This might be possible with the data 
from the full roll-out. 
Unfortunately, it was not possible with the data submitted to the Dry lab part to conduct a 
participant cluster analysis assessment due to inadequate method description. This will be improved 
for the full roll out. 
All in all, as critical point for improvement was revealed and promising data gained prior to the full 
roll out, the objectives for the pilot PT can be regarded as fulfilled.  
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THE PROFICIENCY TEST (PILOT) REPORT OF THE GLOBAL 
MICROBIAL IDENTIFIER INITIATIVE YEAR 2014 
TABLES AND FIGURES 
 
 
Figure 1: Countries participating in the GMI pilot PT 2014 
 
 
Figure 2: How the DNA concentration (ng/µl) was measured prior to library preparation for both 
the bacterial cultures and DNA received.  
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Table 1: The low and high range of DNA concentration (ng/µl) measured for both the bacterial 
cultures and DNA received.  
  Low range (ng/µl) High range (ng/µl) 
GMI14-001-BACT (Salmonella) 14.1 65.2 
GMI14-002-BACT (Salmonella) 14.3 62 
GMI14-001-DNA (Salmonella) 0.2 113 
GMI14-002-DNA (Salmonella) 0.2 128 
GMI14-003-BACT (E. coli) ND ND 
GMI14-004-BACT (E. coli) 9.64 110 
GMI14-003-DNA (E. coli) ND ND 
GMI14-004-DNA (E. coli) 0.2 80.7 
GMI14-005-BACT (S. aureus) 13 216 
GMI14-006-BACT (S. aureus) 9.48 127 
GMI14-005-DNA (S. aureus) 0.2 147 
GMI14-006-DNA (S. aureus) 0.2 87.6 
 
 
Table 2: The low and high range of total DNA amount (µg) measured for both the bacterial cultures 
and DNA received.  
  Low range (µg) High range (µg) 
GMI14-001-BACT (Salmonella) 2.3 6.5 
GMI14-002-BACT (Salmonella) 1.2 6 
GMI14-001-DNA (Salmonella) 0.02 5.65 
GMI14-002-DNA (Salmonella) 0.02 6.4 
GMI14-003-BACT (E. coli) ND ND 
GMI14-004-BACT (E. coli) 1.9 11 
GMI14-003-DNA (E. coli) ND ND 
GMI14-004-DNA (E. coli) 0.02 7.2 
GMI14-005-BACT (S. aureus) 1 43.2 
GMI14-006-BACT (S. aureus) 0.7 25.4 
GMI14-005-DNA (S. aureus) 0.02 7.9 
GMI14-006-DNA (S. aureus) 0.02 4.38 
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Figure 3: Methods applied to measure the DNA quality prior to library preparation for both the 
bacterial cultures and DNA received.  
 
 
Table 3: The low and high range of the measured DNA quality (e.g. RIN or 260/280 ratio) for both 
the bacterial cultures and DNA received.  
  Low range  High range  
GMI14-001-BACT (Salmonella) 1.8 2.07 
GMI14-002-BACT (Salmonella) 1.9 2.08 
GMI14-001-DNA (Salmonella) 2.0 2.0 
GMI14-002-DNA (Salmonella) 1.9 2.0 
GMI14-003-BACT (E. coli) ND ND 
GMI14-004-BACT (E. coli) 1.7 1.95 
GMI14-003-DNA (E. coli) ND ND 
GMI14-004-DNA (E. coli) 2.0 2.0 
GMI14-005-BACT (S. aureus) 1.8 1.95 
GMI14-006-BACT (S. aureus) 1.8 1.97 
GMI14-005-DNA (S. aureus) 2.0 2.0 
GMI14-006-DNA (S. aureus) 2.0 2.0 
 
Table 4: The low and high range of the measured DNA quality (260/230 ratio) for both the 
bacterial cultures and DNA received.  
  Low range  High range  
GMI14-001-BACT (Salmonella) 2.0 2.0 
GMI14-002-BACT (Salmonella) 1.9 1.7 
GMI14-001-DNA (Salmonella) 0.4 0.5 
GMI14-002-DNA (Salmonella) 0.6 0.7 
GMI14-003-BACT (E. coli) ND ND 
GMI14-004-BACT (E. coli) 1.6 1.7 
GMI14-003-DNA (E. coli) ND ND 
GMI14-004-DNA (E. coli) 0.6 0.6 
GMI14-005-BACT (S. aureus) 1.6 2.3 
GMI14-006-BACT (S. aureus) 1.6 2.3 
GMI14-005-DNA (S. aureus) 0.5 0.7 
GMI14-006-DNA (S. aureus) 0.5 0.6 
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Figure 4: Applied sequencing platform used in the proficiency test   
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Table 5: Overview of participants’ use of platforms and tools 
 
Participant 1 2 3 4 9 
Platform Miseq Miseq IonTorrent Miseq Miseq 
Read length  150 300 200 300 301 
Read type Paired-end Paired-end Single-end Paired-end Paired-end 
Assembler* Velvet DNastar in Illumina BaseSpace CLC Genomics Workbench 7 https://cge.cbs.dtu.dk/services/Assembler/ 
Velvet, 
https://www.ebi.ac.uk/~zerbino/velvet/, 
open access 
Applied tools, 
MLST 
 
Inhouse script http://cge.cbs.dtu.dk/services/MLST/ 
MLST Databases of UoW 
(http://mlst.warwick.ac.uk/mlst/dbs/Senterica/); 
(http://mlst.warwick.ac.uk/mlst/dbs/Ecoli) and 
Staphylococcus aureus MLST database 
(http://saureus.mlst.net/) 
http://cge.cbs.dtu.dk/services/MLST 
SRST2 with MLST databases from 
http://pubmlst.org, 
http://katholt.github.io/srst2/, open 
access 
Applied tools, 
resistance genes 
Inhouse script, 
ResFinder http://cge.cbs.dtu.dk/services/ResFinder/ In-house custom pseudomolecules http://cge.cbs.dtu.dk/services/ResFinder 
SRST2 with ResFinder resistance gene 
database, http://katholt.github.io/srst2/, 
open access 
* Participants assembled genomes only used for the MLST and detection antimicrobial resistance genes. 
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Table 6: Determined MLST and antimicrobial resistance genes in Salmonella GMI14-001 for both 
the bacterial culture and DNA received.  
 
  BACT  DNA  
Participant 1 2 3 4 9 1 2 3 4 9 
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Expected MLST  ST19 
Obtained MLST  19
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MLST as 
expected Y Y Y N Y Y Y N N Y Y Y Y N Y Y Y Y N Y 
aroC 10 10 10 10 10 10 10 10 19 10 10 10 10 10 10 10 10 10 19 10 
dnaN 7 7 7 408 7 7 7 7 10 7 7 7 7 19 7 7 7 7 10 7 
hemD 12 12 12 293 12 12 12 12 7 12 12 12 12 293 12 12 12 12 7 12 
hisD 9 9 9 14 9 9 9 553 12 9 9 9 9 14 9 9 9 9 12 9 
purE 5 5 5 444 5 5 5 5 9 5 5 5 5 176 5 5 5 5 9 5 
sucA 9 9 9 109 9 9 9 9 5 9 9 9 9 103 9 9 9 9 5 9 
thrA 2 2 2 104 2 2 2 2 9 2 2 2 2 104 2 2 2 2 9 2 
aac(6')-Iaa X X X X X X X X 
aac(6')-Iy  X  X  X  X  X  X  X  X  X  X 
* Gene reported partly covered or a variant. MLST and resistance genes obtained by participant 
(own tool) and by PT-organizer (CGE tool). Results obtained by PT-organizer (CGE) shaded in 
grey. Deviating results indicated in bold red. 
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Table 7: Quality metrics related to strain GMI14-001-Salmonella 
Participant no / sample type Median 1_1_bac 1_1_dna 2_1_bac 2_1_dna 3_1_bac 3_1_dna 4_1_bac 4_1_dna 5_1_bac 5_1_dna 9_1_bac 9_1_dna 
No. of reads 2334844 1578148 2066146 7538132 3922430 883248 1050687 3456712 2675370 2334844 1642958 5155846 3718744 
Avg. read length 225.9 147.8 144.2 322.4 280.6 308.1 198.7 161.7 199.6 232.1 230.0 248.7 225.9 
No. of reads that map to total reference DNA 2328486 1559868 2050075 7362866 3871448 864925 1024441 3420321 2649326 2328486 1637914 5142540 3687548 
Proportion of reads that map to total reference DNA 98.95 98.84 99.22 97.67 98.70 97.93 97.50 98.95 99.03 99.73 99.69 99.74 99.16 
No. of reads that map to reference chromosome 2305339 1514019 1976660 7132224 3765258 851360 992231 3304033 2579440 2305339 1583269 4960704 3566197 
Proportion of reads that map to reference chromosome 96.86 97.06 96.42 96.87 97.26 98.43 96.86 96.60 97.36 99.01 96.66 96.46 96.71 
No. of reads that map to reference plasmid 1 73253 46368 74407 259706 149147 13857 32579 120719 73253 24666 56573 189593 125973 
Proportion of reads that map to plasmid 1 3.42 2.97 3.63 3.53 3.85 1.60 3.18 3.53 2.76 1.06 3.45 3.69 3.42 
Depth of coverage, total reference DNA 106.8 46.6 59.7 479.4 219.4 53.8 41.1 111.7 106.8 109.1 76.1 258.3 168.3 
Depth of coverage, total reference chromosome 106.0 46.1 58.7 473.3 217.5 54.0 40.6 110.0 106.0 110.2 75.0 254.0 165.9 
Depth of coverage, total reference plasmid #1 138.5 73.0 114.2 891.3 445.6 45.4 68.9 207.8 155.6 60.9 138.5 502.0 303.0 
Total size of assembly 4904497 4902142 4905044 18070847 10403727 4884330 4878995 4904497 4909253 4814319 4912476 4888969 4912967 
Percentage of total size of assembly per total size of DNA 99.1 99.0 99.1 365.0 210.1 98.6 98.5 99.1 99.1 97.2 99.2 98.7 99.2 
Total no. of contigs 110 122 107 57574 32972 56 65 123 110 212 96 168 87 
No. of contigs > 200 bp 96 95 92 57574 32972 56 64 119 109 203 96 168 87 
N50 40872 40853 40877 150592 86699 40704 40660 40872 40912 40121 40939 40743 40943 
NG50 41264 41264 41264 41264 41264 41264 41264 41264 41264 41264 41264 41264 41264 
Compass.pl    
Coverage (by summing "island" lengths) 0.3669 0.4785 0.5180 0.0386 0.0309 0.5246 0.5263 0.3669 0.3425 0.2091 0.3895 0.2489 0.4702 
Validity 0.3705 0.4835 0.5230 0.0107 0.0149 0.5319 0.5342 0.3705 0.3456 0.2151 0.3926 0.2522 0.4740 
Multiplicity 1.0003 1.0003 1.0003 1.0148 1.0094 1.0001 1.0000 1.0004 1.0004 1.0002 1.0002 1.0007 1.0002 
Parsimony (Multiplicity / Validity) 2.5475 2.0691 1.9126 94.4762 67.9015 1.8803 1.8721 2.6998 2.8948 4.6497 2.5475 3.9675 2.1101 
    
REFERENCES Size, total DNA Size, chromosome Size, plasmid #1   
CFSAN18746 Salmonella GMI14-001 4951491    4857558   93933                
 Shading indicates the lowest value for each parameter. 
 Shading indicates the highest value for each parameter. 
All data assembled using the CGE assembler. Deviating results indicated in bold red. 
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Table 8: Determined MLST and antimicrobial resistance genes in Salmonella GMI14-002 for both 
the bacterial culture and DNA received.  
 
  BACT  DNA  
Participant 1 2 3 4 9 1 2 3 4 9 
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Expected MLST  ST599 
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MLST as 
expected Y Y Y Y Y Y Y Y N Y Y Y Y Y Y Y Y Y N Y 
aroC 14 14 14 14 14 14 14 14 599 14 14 14 14 14 14 14 14 14 599 14 
dnaN 7 7 7 7 7 7 7 7 14 7 7 7 7 7 7 7 7 7 14 7 
hemD 3 3 3 3 3 3 3 3 7 3 3 3 3 3 3 3 3 3 7 3 
hisD 12 12 12 12 12 12 12 12 3 12 12 12 12 12 12 12 12 12 3 12 
purE 6 6 6 6 6 6 6 6 12 6 6 6 6 6 6 6 6 6 12 6 
sucA 19 19 19 19 19 19 19 19 6 19 19 19 19 19 19 19 19 19 6 19 
thrA 12 12 12 12 12 12 12 12 19 12 12 12 12 12 12 12 12 12 19 12 
blaCTX-M-15 X X X X X X X X X X X X X X X X X X 
blaSHV-12 X X X X X X X X X X X X X X X X X X X X 
blaTEM-1b X X X X X X X X X X X X X X X X X X X X 
catA2 X* X X X* X X 
dfrA18 X* X X X X X X X X* X X X X X X X 
dfrA19 X X 
ere(A) X* X X X X X X X X X* X X X X X X X X 
floR  X* X X X X X X X X* X X X X X X X 
pbrA-pbrB X X 
qacEdelta1 X X 
QnrB2 X X X X 
QnrB49  X* X X X X X X X* X X X X X X 
strA X X X X X X X X X X X X X X X X 
strB X X X X X X X X X X X X X X X X 
sul1 X X X X X X X X X X X X X X X X X X 
sul2 X X X X X X X X X X X X X X X X X X 
tet(A)  X* X X X X X X X X X* X X X X X X X X 
tet(D) X X X X X X X X X X X X X X X X 
aac(3)-IIb X X 
aac(6')-IIc X X X X X X X X X X X X X X X 
aac(6')-Iy  X* X X X X X X X X X* X X X X X X X X 
aac3  X X 
aacA27 X X 
arr         X                   X           
* Gene reported partly covered or a variant. MLST and resistance genes obtained by participant 
(own tool) and by PT-organizer (CGE tool). Results obtained by PT-organizer (CGE) shaded in 
grey. Deviating results indicated in bold red.
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Table 9: Quality metrics related to strain GMI14-002-Salmonella 
Participant no / sample type Median 1_2_bac 1_2_dna 2_2_bac 2_2_dna 3_2_bac 3_2_dna 4_2_bac 4_2_dna 5_2_bac 5_2_dna 9_2_bac 9_2_dna 
No. of reads 1900294 1881906 1900294 3345320 4480666 1088563 1335123 1475002 2931292 2225058 1246870 2620206 3160322 
Avg. read length 220.0 145.9 139.5 323.0 252.3 313.1 187.2 145.5 196.4 229.9 220.0 279.7 238.9 
No. of reads that map to total reference DNA 1873000 1832839 1873000 3168961 4419037 1065848 1302305 1448703 2907041 2219823 1241530 2613839 3142859 
Proportion of reads that map to total reference DNA 98.56 97.39 98.56 94.73 98.62 97.91 97.54 98.22 99.17 99.76 99.57 99.76 99.45 
No. of reads that map to reference chromosome 1572970 1572970 1529203 2664573 3764174 944841 1080184 1178540 2451004 1968566 1016429 2224595 2572503 
Proportion of reads that map to reference chromosome 84.08 85.82 81.64 84.08 85.18 88.65 82.94 81.35 84.31 88.68 81.87 85.11 81.85 
No. of reads that map to reference plasmid 1 245039 218435 310564 478060 768487 115302 202963 245039 402003 242540 204991 365528 519129 
Proportion of reads that map to plasmid 1 15.09 11.92 16.58 15.09 17.39 10.82 15.58 16.91 13.83 10.93 16.51 13.98 16.52 
No. of reads that map to reference plasmid 2 29318 43946 36149 52903 83356 7157 24468 29056 62268 13368 23737 29318 62035 
Proportion of reads that map to plasmid 2 1.89 2.40 1.93 1.67 1.89 0.67 1.88 2.01 2.14 0.06 1.91 1.12 1.97 
Depth of coverage, total reference DNA 63.2 50.7 49.5 194.0 211.2 63.2 46.2 39.9 108.2 96.7 51.8 138.5 142.3 
Depth of coverage, total reference chromosome 62.4 48.4 45.0 181.6 200.3 62.4 42.6 36.2 101.5 95.5 47.2 131.2 129.6 
Depth of coverage, total reference plasmid #1 81.2 71.7 97.5 347.5 436.3 81.2 85.5 80.2 177.7 125.5 101.5 230.0 279.0 
Depth of coverage, total reference plasmid #2 56.5 69.4 54.6 185.0 227.7 24.3 49.6 45.8 132.4 33.3 56.5 88.8 160.4 
Total size of assembly 5187715 5191393 5187715 5226456 5216534 5169263 5168642 5182363 5190490 5074396 5189716 5182958 5191563 
Percentage of total size of assembly per total size of DNA 98.3 98.4 98.3 99.0 98.8 97.9 97.9 98.2 98.3 96.1 98.3 98.2 98.4 
Total no. of contigs 150 150 186 122 139 77 77 359 171 187 192 147 171 
No. of contigs > 200 bp 113 113 133 122 139 77 76 298 159 167 168 147 148 
N50 43232 43263 43232 43555 43473 43079 43074 43188 43256 42288 43249 43193 43265 
NG50 43982 43982 43982 43982 43982 43982 43982 43982 43982 43982 43982 43982 43982 
Compass.pl   
Coverage (by summing "island" lengths) 0.3733 0.4305 0.3999 0.6110 0.4061 0.3924 0.3634 0.2178 0.3083 0.2698 0.3226 0.4147 0.3733 
Validity 0.3561 0.4109 0.3819 0.5792 0.3856 0.3760 0.3483 0.2082 0.2942 0.2635 0.3079 0.3963 0.3561 
Multiplicity 1.0003 1.0007 1.0004 1.0006 1.0003 1.0003 1.0003 1.0003 1.0004 1.0009 1.0002 1.0003 1.0001 
Parsimony (Multiplicity / Validity) 2.660 2.435 2.620 1.727 2.594 2.660 2.872 4.805 3.401 3.798 3.249 2.524 2.809 
REFERENCES Size, total DNA Size, chromosome Size, plasmid #1 Size, plasmid #2   
CFSAN018747 Salmonella GMI14-002 5277621    4740838    444417    92366            
 Shading indicates the lowest value for each parameter. 
 Shading indicates the highest value for each parameter. 
All data assembled using the CGE assembler. Deviating results indicated in bold red.
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Table 10: Determined MLST and antimicrobial resistance genes in E. coli GMI14-004 for both the 
bacterial culture and DNA received.  
 
  BACT*  DNA*  
Participant 1 2 3 4 9 1 2 3 4 9 
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Expected MLST adK 233, fumC 2, gyrB 29, icD 167, mdH 4, purA 16, recA 4 
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MLST as expected - Y - N N N N Y N Y - Y - N N N N Y N Y 
adK - 233 - 233 233 233 10 233 233 233 - 233 - 138 233 233 10 233 233 233 
fumC - 2 - 2 2 2 7 2 233 2 - 2 - 486 2 2 7 2 233 2 
gyrB - 29 - 29 29 29 12 29 2 29 - 29 - 181 29 29 12 29 2 29 
icD - 167 - 167 167 167 9 167 29 167 - 167 - 167 167 167 9 167 29 167 
mdH - 4 - 4 4 4 5 4 167 4 - 4 - 374 4 4 5 4 167 4 
purA - 16 - 12 16 16 9 16 4 16 - 16 - 1 16 16 9 16 4 16 
recA - 4 - 4 99 215 2 4 16 4 - 4 - 189 99 215 2 4 16 4 
aac(6')-IIc X X X 
aac(6')-Iy              X       
ere(A)             X X       
dfrA18 X X 
QnrB49  X X X 
strA X X X 
strB X X 
sul1 X X X 
sul2 X X X 
floR              X       
tet(A)              X       
tet(D)              X       
blaTEM-1b              X       
 
MLST and resistance genes obtained by participant (own tool) and by PT-organizer (CGE tool). 
Results obtained by PT-organizer (CGE) shaded in grey. Deviating results indicated in bold red. 
*Approximately 15% of the sequence reads does not map to the reference DNA suggesting some 
contamination. 
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Table 11: Quality metrics related to strain GMI14-004-E.coli 
Participant no / sample type Median 1_4_bac 1_4_dna 2_4_bac 2_4_dna 3_4_bac 3_4_dna 4_4_bac 4_4_dna 5_4_bac 5_4_dna 9_4_bac 9_4_dna 
No. of reads 2053210 2053210 2053210 7551992 5069204 1106824 968124 2029982 2562486 1821444 159360 4044036 3744542 
avg. read length 146.42 146.4 146.4 321.9 300.2 304.6 184.2 144.5 179.6 231.3 117.2 263.4 231.3 
No. of reads that map to total reference DNA 1849332 1849332 1849332 6695516 4281238 1016206 781966 1675927 2370359 1728947 129474 3849816 3124724 
Proportion of reads that map to total reference DNA 88.7 90.1 90.1 88.7 84.5 91.8 80.8 82.6 92.5 94.9 81.2 95.2 83.4 
No. of reads that map to reference chromosome 1725471 1725471 1725471 6310855 4078215 1001455 736661 1577019 2315755 1696390 121796 3751380 2941166 
Proportion of reads that map to reference chromosome 94.2 93.3 93.3 94.3 95.3 98.5 94.2 94.1 97.7 98.1 94.1 97.4 94.1 
No. of reads that map to reference plasmid 1 36621 54254 54254 155367 116081 6541 18260 39847 23562 16505 3029 36621 72892 
Proportion of reads that map to plasmid 1 2.33 2.93 2.93 2.32 2.71 0.64 2.34 2.38 0.99 0.95 2.34 0.95 2.33 
No. of reads that map to reference plasmid 2 22643 29445 29445 134065 72093 3799 13268 30037 15280 10093 2372 22643 52222 
Proportion of reads that map to plasmid 2 1.59 1.59 1.59 2.00 1.68 0.37 1.70 1.79 0.64 0.58 1.83 0.59 1.67 
No. of reads that map to reference plasmid 3 62260 72962 72962 279329 171233 14863 25858 62260 46543 25156 4516 103866 111694 
Proportion of reads that map to plasmid 3 3.48 3.95 3.95 4.17 4.00 1.46 3.31 3.71 1.96 1.45 3.49 2.70 3.57 
Depth of coverage. total reference DNA 59.06 51.66 51.66 411.21 245.18 59.06 27.47 46.2 81.21 76.29 2.9 193.48 137.91 
Depth of coverage. total reference chromosome 60.16 49.82 49.82 400.62 241.41 60.16 26.75 44.94 82.01 77.37 2.82 194.88 134.18 
Depth of coverage. total reference plasmid #1 37.6516 150.1 150.1 945.2 658.5 37.7 63.5 108.8 80.0 72.1 6.7 182.3 318.7 
Depth of coverage. total reference plasmid #2 23.76981 88.6 88.6 886.5 444.5 23.8 50.2 89.1 56.4 48.0 5.7 122.5 248.2 
Depth of coverage. total reference plasmid #3 65.66213 154.9 154.9 1304.2 745.5 65.7 69.1 130.5 121.2 84.4 7.7 396.8 374.8 
Total size of assembly 5330032 5397127 5397011 19331077 13180319 5330032 5293359 5367412 5351085 5165154 1278221 5401414 5456878 
*Percentage of total size of assembly per total size of DNA 102.4 103.0 103.0 368.8 251.5 101.7 101.0 102.4 102.1 98.5 24.4 103.0 104.1 
Total no. of contigs 363 409 409 62630 12311 212 243 728 433 363 353 315 334 
No. of contigs > 200 bp 353 387 387 62630 12311 212 242 593 391 353 352 315 334 
N50 44730 44978 44977 161094 109837 44418 44113 44730 44594 43044 43044 45013 45475 
NG50 43682 43682 43682 43682 43682 43682 43682 43682 43682 43682 10653 43682 43682 
Compass.pl                       
Coverage (by summing "island" lengths) 0,001123 0.0019 0.0008 0.0082 0.0591 0.0005 0.0008 0.0013 0.0011 0.0013 0.0010 0.0008 0.0015 
Validity 0,001039 0.0017 0.0008 0.0022 0.0223 0.0005 0.0008 0.0012 0.0010 0.0013 0.0037 0.0007 0.0014 
Multiplicity 1.0000 1.0000 1.0469 1.0236 1.0039 1.0000 1.0000 1.0027 1.0000 1.0142 1.0000 1.0000 1.0173 
Parsimony (Multiplicity / Validity) 794,272 580.5 1389.6 474.5 45.0 2066.7 1300.9 813.9 962.4 794.3 268.7 1390.0 714.3 
REFERENCES Size. total DNA Size. chromosome Size. plasmid #1 Size. plasmid #2 Size. plasmid #3   
CFSAN018749 E. coli GMI14-004 5241609    5071057    52918    48684    68950        
 Shading indicates the lowest value for each parameter. 
 Shading indicates the highest value for each parameter. 
All data assembled using the CGE assembler. Deviating results indicated in bold red. *Approximately 15% of the sequence reads does not 
map to the reference DNA suggesting some contamination.
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Table 12: Determined MLST and antimicrobial resistance genes in S. aureus GMI14-005 for both 
the bacterial culture and DNA received. MLST and resistance genes obtained by participant (own 
data) and by PT-organizer (CGE).  
Results obtained by PT-organizer (CGE) shaded in grey. 
MLST and resistance genes obtained by participant (own tool) and by PT-organizer (CGE tool). 
Results obtained by PT-organizer (CGE) shaded in grey. Deviating results indicated in bold red. 
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Expected MLST ST433 
Obtained MLST 43
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MLST as expected Y Y Y N Y Y Y Y N Y Y Y Y Y Y Y Y Y N Y 
arcC 2 2 2 77 2 2 2 2 433 2 2 2 2 2 2 2 2 2 9 2 
aroE 2 2 2 148 2 2 2 2 2 2 2 2 2 2 2 2 2 2 3 2 
glpF 2 2 2 151 2 2 2 2 2 2 2 2 2 2 2 2 2 2 3 2 
Gmk 2 2 2 109 2 2 2 2 2 2 2 2 2 2 2 2 2 2 1 2 
Pta 6 6 6 112 6 6 6 6 2 6 6 6 6 6 6 6 6 6 1 6 
Tpi 3 3 3 123 3 3 3 3 6 3 3 3 3 3 3 3 3 3 1 3 
yqiL 72 72 72 277 72 72 72 72 3 72 72 72 72 72 72 72 72 72 1 72 
aac(3)-Ik X         X 
blaZ X X X X X X X X X X X X X X X X X X 
czrC X X 
fusA5 X X 
mecA(10) X X X X X X X X X X X X X X X X X X X 
norA X X 
str2 X X X X X X X X X X X X X 
tet(38) X X X X X X X X X X X X X X X X 
vga(A) X X X X 
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Table 13: Quality metrics related to strain GMI14-005-S.aureus 
Participant no / sample type Median 1_5_bac 1_5_dna 2_5_bac 2_5_dna 3_5_bac 3_5_dna 4_5_bac 4_5_dna 5_5_bac 5_5_dna 9_5_bac 9_5_dna 
No. of reads 2380956 2380956 1573038 3008880 4904674 1108555 1053731 5844236 7243770 1422214 1988694 4341732 4201120 
Avg. read length 222.17 143.0 145.6 293.3 306.3 301.9 174.0 192.9 170.9 222.2 225.1 253.8 271.3 
No. of reads that map to total reference DNA 2273852 2273852 1529393 2781882 4770766 1076971 1006197 5731966 6933101 1411053 1964423 4296096 4139215 
Proportion of reads that map to total reference DNA 97.22 95.50 97.20 92.50 97.30 97.20 95.50 98.10 95.70 99.20 98.80 98.90 0.9850 
No. of reads that map to reference chromosome 2107796 2107796 1431222 2573148 4677089 1056727 980277 5539930 6637614 1371752 1898583 4153769 3996512 
Proportion of reads that map to reference 
chromosome 96.64 92.70 93.60 92.50 98.00 98.10 97.40 96.60 95.70 97.20 96.60 96.70 0.9660 
No. of reads that map to reference plasmid 1 118408 167334 98902 231197 118408 20323 26104 199273 305807 40674 68342 147529 147464 
Proportion of reads that map to plasmid 1 3.47 7.36 6.47 8.31 2.48 1.89 2.59 3.48 4.41 2.88 3.48 3.43 0.0356 
Depth of coverage. total reference DNA 151.5 111.4 76.3 279.6 500.8 111.4 60.0 379.0 405.9 107.4 151.5 373.6 384.8 
Depth of coverage. total reference chromosome 146.6 103.4 71.5 259.0 491.7 109.5 58.5 366.8 389.2 104.6 146.7 361.8 372.1 
Depth of coverage. total reference plasmid #1 5441.2 5441.3 3275.4 15421.6 8248.7 1395.2 1032.7 8743.8 11882.8 2055.2 3498.2 8514.2 9097.8 
Total size of assembly 2857685 2846735 2857685 3938151 15282564 2850812 2850496 2881232 2861935 2732285 2762642 2866664 2881158 
Percentage of total size of assembly per total size of 
DNA 97.9 97.6 97.9 135.0 523.7 97.7 97.7 98.7 98.1 93.6 94.7 98.2 98.7 
Total no. of contigs 144 106 124 3907 51020 64 65 144 170 212 182 176 118 
No. of contigs > 200 bp 143 99 100 3907 51020 64 64 143 165 206 182 176 118 
N50 23816 23724 23816 32819 127356 23758 23756 24012 23851 22771 23024 23890 24011 
NG50 24319 24319 24319 24319 24319 24319 24319 24319 24319 24319 24319 24319 24319 
Compass.pl                           
Coverage (by summing "island" lengths) 0.00002323 0.00002323 0.00002323 0.00005029 0.00177341 0.00000020 0.00001171 0.00002323 0.00002323 0.00002323 0.00002323 0.00002323 0.00002323 
Validity 0.00005935 0.00004005 0.00005984 0.00006297 0.00057451 NA 0.00003999 0.00005935 0.00003983 0.00006259 0.00004126 0.00003977 0.00005935 
Multiplicity 1.500 1.0000 1.5000 1.0000 1.0000 NA 2.0000 1.5000 1.0000 1.5000 1.0000 1.0000 1.5000 
Parsimony (Multiplicity / Validity) 25067.4 24971.4 25067.4 15879.6 1740.6 NA 50008.7 25274.0 25104.7 23967.4 24233.7 25146.2 25273.3 
                          
REFERENCES Size. total DNA Size. chromosome Size. plasmid #1   
CFSAN018750 S. aureus GMI14-005 2918141    2913744    4397                
 icates the lowest value for each parameter. 
 icates the highest value for each parameter. 
All data assembled using the CGE assembler. Deviating results indicated in bold red.
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Figure 5: Phylogenetic SNP analysis of strain GMI14-005-S.aureus 
   
 
 2 
Table 14: Determined MLST and antimicrobial resistance genes in S. aureus GMI14-006 for both 
the bacterial culture and DNA received. MLST and resistance genes obtained by participant (own 
data) and by PT-organizer (CGE).  
 
Results obtained by PT-organizer (CGE) shaded in grey. 
MLST and resistance genes obtained by participant (own tool) and by PT-organizer (CGE tool). 
Results obtained by PT-organizer (CGE) shaded in grey. Deviating results indicated in bold red. 
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MLST as expected Y Y Y N Y Y Y Y N Y Y Y Y N Y Y Y Y N Y 
arcC 3 3 3 90 3 3 3 3 9 3 3 3 3 90 3 3 3 3 9 3 
aroE 3 3 3 109 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 
glpF 1 1 1 205 1 1 1 1 3 1 1 1 1 1 1 1 1 1 3 1 
Gmk 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
Pta 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
Tpi 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
yqiL 10 10 10 277 10 10 10 10 1 10 10 10 10 277 10 10 10 10 1 10 
aac(3)-Ik X X 
blaZ X X 
fosB X X 
fusA6 X X 
mecA X X 
norA X X 
tet(38) X X X X X X X X X X X X X X X X X 
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Table 15: Quality metrics related to strain GMI14-006-S.aureus 
Participant no / sample type Median 1_6_bac 1_6_dna 2_6_bac 2_6_dna 3_6_bac 3_6_dna 4_6_bac 4_6_dna 5_6_bac 5_6_dna 9_6_bac 9_6_dna 
No. of reads 2532644 2202384 2532644 3068108 3540796 995773 1030584 5890072 5577444 1525306 1719636 3602104 4799982 
Avg. read length 220.9 146.9 147.1 307.7 306.8 299.7 191.6 186.1 175.2 220.9 222.2 270.9 268.4 
No. of reads that map to total reference DNA 2528015 2193863 2528015 2736537 3470566 961288 997951 5856834 5546314 1521060 1714324 3597045 4791410 
Proportion of reads that map to total reference DNA 99.44 99.60 99.80 89.20 98.00 96.50 96.80 99.40 99.40 99.70 99.70 99.90 99.80 
No. of reads that map to reference chromosome 2528015 2193863 2528015 2736537 3470566 961288 997951 5856834 5546314 1521060 1714324 3597045 4791410 
Proportion of reads that map to reference chromosome 1 1 1 1 1 1 1 1 1 1 1 1 1 
Depth of coverage. total reference DNA 140.1 118.5 136.7 309.7 391.6 105.9 70.3 400.8 357.3 123.5 140.1 358.3 473.0 
Depth of coverage. total reference chromosome 140.1 118.5 136.7 309.7 391.6 105.9 70.3 400.8 357.3 123.5 140.1 358.3 473.0 
Total size of assembly 2665839 2656448 2642838 5934985 11891802 2665814 2665839 2684724 2669724 2539475 2546573 2676813 2680210 
Percentage of total size of assembly per total size of DNA   98.0 97.7 97.2 218.2 437.3 98.0 98.0 98.7 98.2 93.4 93.6 98.4 98.6 
Total no. of contigs 104 41 46 6677 39434 39 41 104 106 169 184 106 87 
No. of contigs > 200 bp 103 40 42 6677 39434 39 40 103 102 168 183 106 87 
N50 22217 22139 22025 49460 99100 22217 22217 22374 22249 21164 21223 22308 22337 
NG50 22663 22663 22663 22663 22663 22663 22663 22663 22663 22663 22663 22663 22663 
                            
Compass.pl                           
Coverage (by summing "island" lengths) 0.0000232 0.0000303 0.0000188 0.0000580 0.0022420 0.0000188 0.0000303 0.0000232 0.0000232 0.0000232 0.0000347 0.0000303 0.0000002 
Validity 0.0000559 0.0000775 0.0000348 0.0000482 0.0009334 0.0000345 0.0000559 0.0000637 0.0000427 0.0000449 0.0000671 0.0000770 NA 
Multiplicity 1.0 1.4 1.0 1.0 1.0 1.0 1.0 1.5 1.0 1.0 1.0 1.4 NA 
Parsimony (Multiplicity / Validity) 20751.7 17828.5 28726.5 20751.7 1071.3 28976.2 17891.5 23550.2 23418.6 22276.1 14892.2 17965.2 NA 
                        
REFERENCES Size. total DNA 
Size. 
chromosome   
CFSAN018751 S. aureus GMI14-006 2719423 2719423               
 Shading indicates the lowest value for each parameter. 
 Shading indicates the highest value for each parameter. 
All data assembled using the CGE assembler. Deviating results indicated in bold red.
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Figure 6: Phylogenetic SNP analysis of strain GMI14-006-S.aureus 
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Figure 6: Number of reads per strain and per participant 
 
Results for participant 2 omitted for both sample types of strain 1, 4, 5, and 6. The whiskers 
represent minimum and maximum values (range) and the box represent the Q1, Median, and Q3, 
respectively.  
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Figure 7: Depth (x) of coverage per strain and per participant 
 
 
Results for participant 2 omitted for both sample types of strain 1, 4, 5, and 6. The whiskers 
represent minimum and maximum values (range) and the box represent the Q1, Median, and Q3, 
respectively. 
 
  
0
50
100
150
200
250
300
350
400
450
500
GMI‐001 GMI‐002 GMI‐004 GMI‐005 GMI‐006
X
Strain code
Depth of coverage, total reference DNA
   
 
 4 
Figure 8: Total number of contigs per strain and per participant 
 
Results for participant 2 omitted for both sample types of strain 1, 4, 5, and 6. The whiskers 
represent minimum and maximum values (range) and the box represent the Q1, Median, and Q3, 
respectively. 
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Figure 9: N50 (average length (bp) of sequences) per strain and per participant 
 
Results for participant 2 omitted for both sample types of strain 1, 4, 5, and 6. The whiskers 
represent minimum and maximum values (range) and the box represent the Q1, Median, and Q3, 
respectively. 
 
 
 
 
Table 16: Summary of assemblers used by participants of the dry-lab-component. 
Assembler N 
CLC Genomics Workbench 7 1 
n/a 2 
NGOPT (http://sourceforge.net/projects/ngopt/) 2 
Velvet (https://www.ebi.ac.uk/~zerbino/velvet/) 3 
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Table 17: Diversity of reference genomes within each taxonomic group used by the participating 
laboratories. 
Reference N 
Staphylococcus aureus M1 1 
Staphylococcus aureus NCTC 8325 1 
Staphylococcus aureus MSSA476 1 
Staphylococcus aureus USA300 1 
Staphylococcus aureus MSSA476 2 
Staphylococcus aureus M013 1 
Staphylococcus aureus MW2 1 
Escherichia coli O111:H- str 11128 6 
Escherichia coli ATCC BAA-2209  1 
Escherichia coli O157:H7 1 
Salmonella Typhimurium SL1344 1 
Salmonella Typhimurium SL1344 1 
Salmonella Typhimurium 14028S 1 
Salmonella Typhimurium LT2 5 
 
Table 18: Number of individuals (N) and length of the matrices constructed by each participant for 
each of the three Dry lab datasets. 
 E. coli S. aureus S. Typhimurium 
Lab N Length N Length N Length 
1 23 18811 25 1590 21 11481 
2 22 58751 24 22723 20 15304 
3 22 3806 24 11378 19 8662 
4 22 36611 24 1439 20 18181 
5 23 13196 25 1775 21 10567 
6 18 150447 25 5903 22 19881 
7 23 26875 25 4373 21 15586 
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Figure 10: Scatterplot illustrating the differences in the size of the SNP matrix (x-axis) and average 
pairwise distances among samples (y-axis) for each of the three datasets (coloring of points) across 
the different participants (individual points)  
 
 
Figure 11: Heatmaps illustrating the number of pairwise SNP differences within each of the three 
datasets for each participating laboratory. The y-axis are pairwise comaprisons and sorted to be the 
same across the participants. The figure illustrates that despite differences in protocols and number 
of SNPs that the participants often detected similar patterns of differentiation but that was not 
always the case (e.g., Lab3 S. aureus detected large pairwise differences among all samples, which 
was not the case for the other participants).  
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Table 19: The number of clusters within each dataset identified by the participants and the method 
described to identify those clusters. 
Lab S. Typhimurium E. coli S. aureus Method 
1 2 2 6 CTree (http://www.phylogenetictrees.com/ctree.php) 
2 2 n/a 2 Relative SNP differences 
3 Ill-formatted 
result from 
SurveyMonkey 
4 2  
4 3 2 3 Not described 
5 3 2 2 Not described 
6 3 3 2 Not described 
7 3 4 3 SNP differences 
8 6 5 4 Based on phylogenetic analysis, MLST and resistance genes 
 
 
 
Denmark, June 2014 
 
Prenotification for GMI proficiency test pilot, 2014 
GMI is a global, visionary taskforce of scientists and other stakeholders who shares an aim of 
making novel genomic technologies and informatics tools available for improved global patient 
diagnostics, surveillance and research, by developing needs- and end-user-based data exchange 
and analysis tools for characterization of all microbial organisms and microbial communities. 
WHY PARTICIPATE IN THE GMI PROFICIENCY TEST? 
The proficiency test (PT) represents an important tool for the production of reliable laboratory 
results of consistently good quality within the area of DNA preparation, sequencing, and analysis 
(e.g. phylogeny). 
 
WHAT IS OFFERED IN THE GMI PROFICIENCY TEST? 
This inter-laboratory test performance is provided to ensure harmonization and standardization in 
whole genome sequencing and data analysis, with the aim to produce comparable data for the 
GMI initiative.   
The GMI working group 4 (WG4) steered by the United States Food and Drug Administration, 
Microbiologics, and Technical University of Denmark has prepared this proficiency test. The PT 
consists of three parts, each of which are optional, and include assessing (1a) the laboratory’s DNA 
preparation and sequencing procedures, (1b) the laboratory’s sequencing output, and (2) the 
laboratory’s procedure to cluster and distinguish samples based on the analysis of whole-genome-
sequence data.  
The proficiency test focuses on Salmonella Typhimurium, Escherichia coli and Staphylococcus 
aureus, and allows for sign-up for each species separately. Note that item 1a and item 1b are 
parallel; i.e. when signing up for 1a for one species, the participation in 1b is connected.  
The three items consist of 
1a) DNA extraction, purification, library-preparation, and whole-genome-sequencing of six 
bacterial cultures; two Salmonella Typhimurium strains, two Escherichia coli strains* and 
two Staphylococcus aureus strains. Participants will be requested to upload reads to an ftp-
site and optionally also identify the Multi Locus Sequence Type (MLST) of the strains as 
well as the resistance genes present in the strains if that is something that is routinely done 
within the laboratory. 
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1b) Perform whole-genome-sequencing of pre-prepared DNA delivered by Working Group 
4 of the GMI of the same six bacterial strains mentioned in clause 1a. 
2) Phylogenetic/clustering analysis of three datasets each including fastq data from circa 20 
genomes of S. Typhimurium, E. coli and S. aureus, respectively.  
 
WHO SHOULD PARTICIPATE IN THE GMI PROFICIENCY TEST? 
All laboratories of the GMI community performing whole-genome-sequencing and/or 
phylogenetic analysis are invited to participate, in particular, laboratories frequently submitting 
data to NCBI, EBI and DDBJ. For the GMI proficiency test pilot, however, participation is by 
invitation only. 
 
COST FOR PARTICIPATING IN THE GMI PROFICIENCY TEST 
There is no participation fee in the GMI proficiency test. Laboratories should, however, cover the 
expenses for parcel shipment if possible. If FedEx has ‘Dangerous Goods-service’ in your country or 
if you have a DHL-account number, please provide your FedEx or DHL import account number (for 
import of UN3373 Biological Substance Category B) in the sign-up form or, alternatively, to the PT 
Coordinator (please find contact information below). We need this information at this stage to 
save time and resources. Participating laboratories are responsible for all costs related to taxes or 
custom fees applied by their country as well as those related to the analysis.  
 
HOW TO SIGN UP FOR THE GMI PROFICIENCY TEST 
This link will open a sign-up webpage: http://www.globalmicrobialidentifier.org/Workgroups/GMI-
Proficiency-Test-pilot-for-2014 
In this webpage, you will be asked to provide the following information: 
• Name of institute/organization and main contact person 
• Complete mailing address for shipment of bacterial isolates and DNA 
• Telephone and fax number, e-mail address 
• FedEx or DHL import account number (if available) 
• Items of the GMI PT you plan to participate in (item 1a, 1b  and/or 2; Salmonella, E. coli, S. 
aureus) 
 
If you experience any problem in the sign-up webpage please contact the GMI PT Coordinator 
Susanne Karlsmose: E-mail suska@food.dtu.dk; fax +45 3588 6341.  
 
TIMELINE FOR SHIPMENT OF ISOLATES, DNA AND DATA-FILES  
The bacterial isolates and the DNA will be shipped from DTU Food late June 2014 (pilot PT).  
In order to minimize delays, please send a valid import permit to the PT coordinator. Please apply 
for a permit to receive the following bacterial cultures or DNA (according to your level of 
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participation): “UN3373, Biological Substance Category B”: two Salmonella strains, one Escherichia 
coli strain*, two S. aureus strains.   
Note: None of the bacterial cultures are enterotoxin producing. 
 
AVAILABILITY OF PROTOCOLS 
When isolates and DNA have been dispatched and data files been made available for download, 
protocols and all relevant information will be available for download from the website: 
http://www.globalmicrobialidentifier.org/Workgroups/About-the-GMI-Proficiency-Test-Pilot-
2014. 
 
DEADLINE FOR SUBMITTING RESULTS 
Results must be submitted to an ftp-site as described in the protocol by 15th August 2014. Full 
anonymity is ensured, and only the PT-organizers will have access to your results. An overall report 
summarizing the results will be published. 
Deadline for sign-up for the GMI pilot PT 2014 is June 23rd 2014  
* Due to issues in the preparations for the pilot PT, one set of Escherichia coli culture and DNA, only, will be included in 
the pilot PT, i.e. in total, two Salmonella Typhimurium, one Escherichia coli and two Staphylococcus aureus. 
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PROTOCOL for GMI proficiency test pilot, 2014 
 
 
1 OVERVIEW AND OBJECTIVES ...............................................................................................  1 
2 INTRODUCTION ..................................................................................................................  2 
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3.1 Shipping, receipt and storage of bacterial strains .....................................................  3 
3.2 Using FTP to transfer files ........................................................................................  3 
3.3 Supplied test material .............................................................................................  3 
3.4 Procedure and analysis of test material ...................................................................  4 
4 REPORTING OF RESULTS AND EVALUATION ........................................................................  5 
 
1 OVERVIEW AND OBJECTIVES 
The proficiency test pilot, 2014, consists of three general parts: 
1a. DNA extraction, purification, library-preparation, and whole-genome-sequencing 
from live cultures 
1b.  Whole-genome-sequencing of pre-prepared DNA  
2.  Phylogenetic/clustering analysis of three fastq datasets 
The main objective of this proficiency test is to quantify differences among laboratories in order to 
facilitate the development of reliable laboratory results of consistently good quality within the 
area of DNA preparation, sequencing, and analysis (e.g. phylogeny). This ensures that the 
discrepancies and differences among laboratories are known and will contribute to the 
standardization of whole genome sequencing and data analysis, with the aim to produce 
comparable data for the GMI initiative. A further objective is to assess and improve the uploaded 
data to databases such as NCBI, EBI and DDBJ.  
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2 INTRODUCTION 
GMI is a global, visionary taskforce of scientists and other stakeholders who shares an aim of 
making novel genomic technologies and informatic tools available for improved global patient 
diagnostics, surveillance and research. This, by developing needs- and end-user-based data 
exchange and analysis tools for characterization of all microbial organisms and microbial 
communities.  
The GMI working group 4 (WG4) steered by the United States Food and Drug Administration, 
Microbiologics, and Technical University of Denmark has prepared this proficiency test (PT). The 
PT consists of three parts, each of which are optional, and include assessing (1a) the laboratory’s 
DNA preparation and sequencing procedures, (1b) the laboratory’s sequencing output, and (2) the 
laboratory’s procedure to analyse a whole-genome-sequencing dataset and distinguish between 
clonally related and sporadic genomes.  
The proficiency test focuses on Salmonella enterica serovar Typhimurium, Escherichia coli strain 
and Staphylococcus aureus, and allows for sign-up for each species separately. Note that item 1a 
and item 1b are parallel; i.e. when signing up for 1a for one species, the participation in 1b is 
connected.  
The three items consist of 
1a) DNA extraction, purification, library-preparation, and whole-genome-sequencing of six 
bacterial cultures; two Salmonella Typhimurium strains, two Escherichia coli strain and two 
Staphylococcus aureus strains. Participants will be requested to upload reads to an ftp-site 
and optionally also identify the Multi Locus Sequence Type (MLST) of the strains as well as 
the resistance genes present in the strains if that is something that is routinely done within 
the laboratory. 
1b) Whole-genome-sequencing of pre-prepared DNA of the same six bacterial strains 
mentioned in clause 1a. 
2) Phylogenetic/clustering analysis of three datasets each including fastq data from circa 20 
genomes of S. Typhimurium, E. coli and S. aureus, respectively.  
Institutes/organizations which signed up to participate will receive the PT-material (bacterial 
strains, DNA and/or the login for download of datasets) according to the information reported in 
the sign-up form.   
To achieve the objective of assessing and improving the uploaded data to databases such as NCBI, 
EBI and DDBJ, the laboratory work analysis performed for this PT should be done by using the 
methods routinely used in your laboratory. 
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3 OUTLINE OF THE GMI PT 
3.1 Shipping, receipt and storage of bacterial strains 
In June 2014, around 10 laboratories located worldwide will receive a parcel containing the two S. 
Typhimurium strains, two E. coli strains and two S. aureus strains together with corresponding 
purified DNA (according to information reported in the sign-up form). All bacterial strains and DNA 
are shipped as UN3373, Biological substance category B. Those who signed up for item 2 
(phylogenetic analysis) will receive information and login for downloading the three datasets.  
 Please confirm receipt of the parcel through the confirmation form enclosed in the shipment.  
The bacterial strains are shipped lyophilised as KwikStik’s (see below for additional info on 
handling). On arrival, the KwikStik’s must be refrigerated until handling in the laboratory.  
The bacterial DNA is shipped as dried samples using a DNA stabilizing agent (DNAstable® Plus, 
Biomatrica). On arrival, either rehydrate your sample and store the liquid samples at room 
temperature in closed tubes, to prevent evaporation. Or store the dried samples in either  
(a) a dry storage cabinet at room temperature (15-25°C or 59-77°F) or  
(b) a heat-sealed, moisture-barrier bag along with a silica gel desiccant pack. 
3.2 Using FTP to transfer files 
For download of fastq files for item 2 and for upload of results, an ftp-server is used. The 
proficiency test organizer will provide each participant with username and login for this purpose. 
The ftp-site which will be used for this purpose is cgebase.cbs.dtu.dk. For information on how to 
transfer files, please see Appendix 1. 
3.3 Supplied test material  
3.3.1 Item 1a; Bacterial cultures 
The procedure for reconstitution of the bacterial cultures should follow the manufacturer’s 
procedures as presented in the instructional video or the written instructions on their website 
(see http://microbiologics.com/s.nl/sc.7/category.98564/.f or http://microbiologics.com/Support-
Center/KWIK-STIK-trade).  
MSDS for Kwik stik are found here: http://microbiologics.com/Support-Center/Lyophilized-
Microorganism-Preparations.  
The bacterial cultures supplied have been sequenced multiple times and the genomes have been 
closed. Therefore, the PT-organizers encourage participants to maintain these bacterial strains in 
their strain collection and apply them as part of future internal quality control. 
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3.3.2 Item 1b; DNA 
The supplied DNA has been stabilized by DNA Stable®plus 
(http://www.biomatrica.com/media/dnastable%20Plus/3004-0112.pdf). Each vial contains a 
minimum of 3ug DNA. Before use, the samples should be re-suspended in 100 µl water or aqueous 
buffer and mixed by gentle pipetting or vortexing for 15 min (according to above mentioned 
protocol). Rehydrated samples can be stored at room temperature and used directly in 
downstream application. 
3.3.3 Item 2; Fastq data set 
Three datasets, one for each of S. Typhimurium, E. coli and S. aureus, will be available for 
download from the ftp-site ‘cgebase.cbs.dtu.dk’. Login to the ftp-site will be provided directly to 
each participant. Each dataset will consist of the original fastq files (i.e., whole genome sequence 
data) from circa 20 samples for phylogenetic cluster analysis based on a tool of the laboratory’s 
own choice; SNP-calling, gene-by-gene, etc.  
3.4 Procedure and analysis of test material 
3.4.1 Item 1a and 1b; Bacterial cultures and DNA 
Subculture the bacterial strains on a relevant growth medium of the laboratory’s own choice and 
incubate. Following incubation and assessment of purity of the bacterial cultures, perform DNA 
extraction and whole-genome-sequencing according to the laboratory’s standard procedure.  
For the purified PT-DNA received, perform whole-genome-sequencing according to the 
laboratory’s standard procedure.  
For both bacterial cultures and DNA (items 1a and 1b), register relevant information related to the 
methods applied via https://www.surveymonkey.com/s/pilot-
PT_2014_bacterial_cultures_and_DNA (also see Appendix 2). Upload the non-assembled sequence 
data obtained (e.g., fastq-files, sff files) for each of the bacterial cultures and DNA-samples to the 
ftp-site (cgebase.cbs.dtu.dk) using your individual login and password. Appendix 2 also describes 
the submission of results obtained when analyzing the sequences as regards the detected 
antimicrobial resistance genes and as regards the Multi Locus Sequence Type of the bacterial 
strain. 
For both bacterial cultures and DNA (items 1a and 1b), the submitted sequence data (fastq-files) 
will be evaluated according to the following specific quality markers: Read length (bp), N50 (bp), 
total number of contigs and total length of sequence (bp) including percentage of reference 
genome covered. In addition, the PT-organizers will assemble the submitted reads and compare 
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these assemblies 1) towards the relevant closed genome to assess the sequence error rate and 
coverage of the scaffold and 2) between the obtained sequences in items 1a and 1b. 
3.4.2 Item 2; Fastq data set 
The three fastq datasets should be downloaded from the ftp-site. They are organized into three 
different .zip archives appropriately labeled with the taxon they represent. Within each archive 
the participant will find the paired-end reads, a tab-delimited file containing info about the 
isolates, and a pdf document with questions to be answered based on the results of the analysis. 
The objective associated with this dataset is to assess the variability of laboratories in the clusters 
identified through the analysis of next-generation sequencing data. As such, the participant should 
employ their preferred method for constructing a matrix (e.g., gene, SNP, presence/absence, etc.) 
and for clustering samples (e.g., distance-, maximum-likelihood-, Bayesian-based).  
Assessment of the submitted results from the analysis of the datasets is based on two criteria: 1) 
the concordance among laboratories in their answers to the questions within the pdf document 
and 2) the concordance between participants’ in the information content contained in the matrix 
and the relationships among samples from the clustering analyses (i.e., the topology).  
Specifically, four types of files should be submitted: 
For each dataset: 
1. The DNA sequence matrix used for clustering (e.g., a fasta, phylip, or nexus formatted file) 
2. If relevant, also submit the distance matrix file 
3. The clusters themselves (e.g., a newick or nexus formatted tree file) 
4. A spreadsheet listing the obtained coverage and the number of bases sequenced 
(download template from the ‘shared’ ftp-site) 
For each strain: 
5. For each strain, one file containing the assembled contigs should be submitted. The 
filename should consist of username, strain name and type of file, all in lowercase letters, 
e.g. ‘username_strainname_typeoffile.xxx’ 
 
From the files containing assembled contigs, the proficiency test organizers will calculate N50, 
number of contigs, size of the chromosome and the longest contig.  
Via the Internet-based survey (https://www.surveymonkey.com/s/pilot-PT_2014_FASTQ_dataset; 
see also Appendix 3), answers should be submitted to the questions related to the Fastq data set 
section.  
4 REPORTING OF RESULTS AND EVALUATION 
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The results, which should be captured and entered into the Internet-based survey 
(https://www.surveymonkey.com/s/pilot-PT_2014_bacterial_cultures_and_DNA and  
https://www.surveymonkey.com/s/pilot-PT_2014_FASTQ_dataset), are listed in Appendix 2 and 3. 
Results must be submitted electronically no later than 15 August 2014. Immediately after this 
date, the survey will be closed and results submitted to the Internet-based survey and to the ftp-
site will be evaluated. Delayed submission of results will not be accepted. All submitted results will 
be summarized in a report which will be publicly available. Individual results will be anonymized. 
For the evaluation of the results, no official GMI quality threshold is currently available and 
therefore no acceptance limit has been defined for this proficiency test.  
We are looking forward to receiving your results.  
If you have any questions or concerns, please do not hesitate to contact us:  
In relation issues related to dry-lab issues, please contact: 
James Pettengill 
FDA 
Maryland, US 
E-mail: James.Pettengill@fda.hhs.gov  
 
In relation to other issues, e.g. organizational issues, please contact the EQAS Coordinator: 
Susanne Karlsmose 
National Food Institute, Technical University of Denmark 
Kemitorvet, Building 204 ground floor, DK-2800 Kgs. Lyngby - DENMARK 
Tel: +45 3588 6601, Fax: +45 3588 6341 
E-mail: suska@food.dtu.dk 
___   ___   ___ 
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Appendix 1 
Using FTP to transfer files 
FTP is an acronym for File Transfer Protocol and is used to transfer files between computers on a 
network. To access the folder for upload or download of files, do as described below. 
Obtain access to upload or download files by using the relevant login provided by the proficiency 
test organizer. 
 
Using a Windows-computer: 
Open the Documents folder, and type ‘ftp://cgebase.cbs.dtu.dk/’ in the Address bar. 
Enter you username and password, click “Log on”. 
 
Using a Mac-computer: 
FileZilla FTP client: 
- Download and install FileZilla (https://filezilla-project.org/)   
- Host:cgebase.cbs.dtu.dk   
- Type username and password 
- Connect 
 
Or  
 
Finder Mac application: 
- In the Finder, choose Go > “Connect to Server,” and wait for the pop-up window to show up. 
- Specify server address ftp://cgebase.cbs.dtu.dk and click “Connect” 
- In the new pop-up window enter you username and password, click “Connect” 
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GMI Proficiency Testing Pilot (PT) 2014 - bacterial cultures and DNA
This survey seeks to capture info on participants' sequence procedures and specifications in relation to the tested 
bacterial cultures and DNA. 
 
The survey consists of five sections, collecting information on  
1. User Information and Sample Storage 
2. Bacterial Culture; DNA Isolation, Handling and Processing  
3. Received DNA; Handling and Processing  
4. Sequencing 
5. Analysis of sequences; MLST and antimicrobial resistance genes 
 
If you have any questions or feedback for the submission of data via this survey, please contact the PT Coordinator, 
Susanne Karlsmose (suska@food.dtu.dk), at the Technical University of Denmark. 
 
Note: An asterisk (*) indicates a question that requires an answer. 
___________________  
 
GMI is a global, visionary taskforce of scientists and other stakeholders who shares an aim of making novel genomic 
technologies and informatics tools available for improved global patient diagnostics, surveillance and research, by 
developing needs­ and end­user­based data exchange and analysis tools for characterization of all microbial 
organisms and microbial communities. 
 
 
 
 
1. Institute name / Organization name 
2. Department name
3. Name of person responsible for the handling of the PT­material
4. Dates in relation to the handling of the PT­material (date for upload of sequence 
data)
 
Introduction
*
*
*
*
DD MM YYYY
PT­material reception date / /
Test start of processing the bacterial cultures / /
Completion of processing the bacterial cultures / /
Test start of processing the DNA / /
Completion of processing the DNA (upload of sequence 
data)
/ /
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5. Storage conditions of the bacterial cultures in the time between reception and 
processing: 
(please select one answer)
6. Storage conditions of the DNA in the time between reception and processing: 
(please select one answer)
7. How were the bacterial cultures cultivated:
*
*
 
BACTERIAL CULTURES received
*
7.1 ­ Type of agar media/liquid broth:
7.2 ­ Incubation time:
7.3 ­ Incubation temperature:
­80˚C nmlkj
­20˚C nmlkj
4˚C nmlkj
Room temperature
 
nmlkj
No storage time
 
nmlkj
We did not receive bacterial cultures for this PT
 
nmlkj
Other
 
nmlkj
If other, please define 
­80˚C nmlkj
­20˚C nmlkj
4˚C nmlkj
Room temperature
 
nmlkj
No storage time
 
nmlkj
Other
 
nmlkj
If other, please define 
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8. For the Gram­negative bacterial cultures; DNA extraction procedure:
9. For the Gram­positive bacterial cultures; DNA extraction procedure:
10. For bacterial cultures, DNA concentration (ng/µl) prior to library preparation was 
measured on (please select one answer) 
11. Measure of DNA concentration (ng/µl)
*
8.1 ­ If manual extraction; kit used:
8.2 ­ If manual extraction, modifications to 
kit protocol:
8.3 ­ If automatic extraction; robot used:
8.4 ­ If automatic extraction; specific 
protocol:
8.5 ­ If automatic extraction; modifications 
to protocol:
*
9.1 ­ If manual extraction; kit used:
9.2 ­ If manual extraction, modifications to 
kit protocol:
9.3 ­ If automatic extraction; robot used:
9.4 ­ If automatic extraction; specific 
protocol:
9.5 ­ If automatic extraction; modifications 
to protocol:
*
11.1 GMI14­001­BACT (Salmonella)
11.2 GMI14­002­BACT (Salmonella)
11.3 GMI14­003­BACT (E. coli)
11.4 GMI14­004­BACT (E. coli)
11.5 GMI14­005­BACT (S. aureus)
11.6 GMI14­006­BACT (S. aureus)
Qubit
 
nmlkj
Nanodrop
 
nmlkj
DNA concentration not measured
 
nmlkj
Other
 
nmlkj
If other, please specify: 
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12. Total DNA amount (microgram)
13. For bacterial cultures, DNA quality (e.g. RIN, 260/280 ratio and/or 260/230 ratio) prior 
to library preparation was measured on (please select one answer) 
14. Measure of DNA quality (e.g. RIN or 260/280 ratio)
15. If relevant; measure of DNA quality (260/230 ratio):
12.1 GMI14­001­BACT (Salmonella)
12.2 GMI14­002­BACT (Salmonella)
12.3 GMI14­003­BACT (E. coli)
12.4 GMI14­004­BACT (E. coli)
12.5 GMI14­005­BACT (S. aureus)
12.6 GMI14­006­BACT (S. aureus)
14.1 GMI14­001­BACT (Salmonella)
14.2 GMI14­002­BACT (Salmonella)
14.3 GMI14­003­BACT (E. coli)
14.4 GMI14­004­BACT (E. coli)
14.5 GMI14­005­BACT (S. aureus)
14.6 GMI14­006­BACT (S. aureus)
15.1 GMI14­001­BACT (Salmonella)
15.2 GMI14­002­BACT (Salmonella)
15.3 GMI14­003­BACT (E. coli)
15.4 GMI14­004­BACT (E. coli)
15.5 GMI14­005­BACT (S. aureus)
15.6 GMI14­006­BACT (S. aureus)
 
DNA received
Bioanalyser nmlkj
Nanodrop nmlkj
DNA quality not measured nmlkj
Other nmlkj
If other, please specify: 
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16. For the DNA received, DNA concentration (ng/µl) prior to library preparation was 
measured on (please select one answer) 
17. Measure of DNA concentration (ng/µl)
18. Total DNA amount (microgram)
19. For the DNA received, DNA quality (e.g. RIN, 260/280 ratio and/or 260/230 ratio) prior 
to library preparation was measured on (please select one answer) 
17.1 GMI14­001­DNA (Salmonella)
17.2 GMI14­002­DNA (Salmonella)
17.3 GMI14­003­DNA (E. coli)
17.4 GMI14­004­DNA (E. coli)
17.5 GMI14­005­DNA (S. aureus)
17.6 GMI14­006­DNA (S. aureus)
18.1 GMI14­001­DNA (Salmonella)
18.2 GMI14­002­DNA (Salmonella)
18.3 GMI14­003­DNA (E. coli)
18.4 GMI14­004­DNA (E. coli)
18.5 GMI14­005­DNA (S. aureus)
18.6 GMI14­006­DNA (S. aureus)
Qubit nmlkj
Nanodrop nmlkj
DNA concentration not measured nmlkj
Other nmlkj
If other, please specify: 
Bioanalyser
 
nmlkj
Nanodrop
 
nmlkj
DNA quality not measured
 
nmlkj
Other
 
nmlkj
If other, please specify: 
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20. Measure of DNA quality (e.g. RIN or 260/280 ratio)
21. If relevant; measure of DNA quality (260/230 ratio): 
22. What protocol was used to prepare the sample library for sequencing? For 
commercial kits please provide the full kit name, item number, and lot number if 
possible. For noncommercial kits please provide a citation for the protocol, or submit a 
summary of the protocol. Please note any deviations from the kit or cited protocol
20.1 GMI14­001­DNA (Salmonella)
20.2 GMI14­002­DNA (Salmonella)
20.3 GMI14­003­DNA (E. coli)
20.4 GMI14­004­DNA (E. coli)
20.5 GMI14­005­DNA (S. aureus)
20.6 GMI14­006­DNA (S. aureus)
21.1 GMI14­001­DNA (Salmonella)
21.2 GMI14­002­DNA (Salmonella)
21.3 GMI14­003­DNA (E. coli)
21.4 GMI14­004­DNA (E. coli)
21.5 GMI14­005­DNA (S. aureus)
21.6 GMI14­006­DNA (S. aureus)
 
SEQUENCING
For commercial kits; full kit name:
For commercial kits; item number:
For commercial kits; lot number:
For noncommercial kits; citation for the protocol:
For noncommercial kits; summary of the protocol:
Deviations from the kit or cited protocol
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23. Please indicate the sequencing platform you used in the proficiency test 
(please select one answer) 
24. Sequencing details #1  
(please select one answer) 
25. Sequencing details #2: 
For the sequencing, the read length (bp) was set to be (expected read length)
 
26. Reads trimmed before upload 
(please select one answer) 
*
*
Ion Torrent PGM
 
nmlkj
Ion Torrent Proton
 
nmlkj
Genome Sequencer Junior System (454)
 
nmlkj
Genome Sequencer FLX System (454)
 
nmlkj
Genome Sequencer FLX+ System (454)
 
nmlkj
PacBio RS
 
nmlkj
PacBio RS II
 
nmlkj
HiScanSQ
 
nmlkj
HiSeq 1000
 
nmlkj
HISeq 1500
 
nmlkj
HiSeq 2000
 
nmlkj
HiSeq 2500
 
nmlkj
Genome Analyzer lix
 
nmlkj
MiSeq Benchtop Sequencer
 
nmlkj
ABI SOLiD
 
nmlkj
other
 
nmlkj
If other, please specify 
Single­end nmlkj
Paired­end nmlkj
Not relevant nmlkj
Yes nmlkj
No nmlkj
If trimmed, which tool was applied (in the text box below, please insert name and URL (if possible)) 
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27. For this item (1a and 1b) in the proficiency test, assembly is not requried. 
If, however, you were to assemble your sequences, which assembly tool would you 
apply? in the text box below, please insert name and URL (e.g. Velvet, 
https://www.ebi.ac.uk/~zerbino/velvet/, open access)
28. If any, which method was used to characterize or differentiate isolates?
29. Did you determine which antimicrobial resistance genes were present in the 
sequenced DNA?
30. For the DNA from the received bacterial culture, if analysis was performed based on 
the sequence analysis, which MLST­type does the isolate belong to, or which alleles 
characterize the isolate? 
Assembly tool:
 
ANALYSIS of sequences
30.1 GMI14­001­BACT (Salmonella)
30.2 GMI14­002­BACT (Salmonella)
30.3 GMI14­003­BACT (E. coli)
30.4 GMI14­004­BACT (E. coli)
30.5 GMI14­005­BACT (S. aureus)
30.6 GMI14­006­BACT (S. aureus)
MLST gfedc
Allele­based gfedc
Gene­by­gene­based gfedc
SNP­based gfedc
None gfedc
Other (please specify) 
Yes nmlkj
No nmlkj
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31. For the DNA from the received bacterial culture, if analysis for antimicrobial 
resistance genes was performed based on the sequence analysis, which antimicrobial 
resistance genes does the isolate harbour?
32. For the received DNA, if MLST­analysis was performed based on the sequence 
analysis, which MLST­type does the isolate belong to, or which alleles characterize the 
isolate? 
33. For the received DNA, if analysis for antimicrobial resistance genes was performed 
based on the sequence analysis, which antimicrobial resistance genes does the isolate 
harbour?
34. For the detection of the Multi Locus Sequence Type, which tool did you apply? in 
the text box below, please insert name and URL (e.g. MLST 1.7 (MultiLocus Sequence 
Typing), http://cge.cbs.dtu.dk/services/MLST/, open access)
35. For the detection of the resistance genes harboured in the seqences, which tool did 
you apply? in the text box below, please insert name and URL (e.g. ResFinder, 
http://cge.cbs.dtu.dk/services/ResFinder/, open access)
31.1 GMI14­001­BACT (Salmonella)
31.2 GMI14­002­BACT (Salmonella)
31.3 GMI14­003­BACT (E. coli)
31.4 GMI14­004­BACT (E. coli)
31.5 GMI14­005­BACT (S. aureus)
31.6 GMI14­006­BACT (S. aureus)
32.1 GMI14­001­DNA (Salmonella)
32.2 GMI14­002­DNA (Salmonella)
32.3 GMI14­003­DNA (E. coli)
32.4 GMI14­004­DNA (E. coli)
32.5 GMI14­005­DNA (S. aureus)
32.6 GMI14­006­DNA (S. aureus)
33.1 GMI14­001­DNA (Salmonella)
33.2 GMI14­002­DNA (Salmonella)
33.3 GMI14­003­DNA (E. coli)
33.4 GMI14­004­DNA (E. coli)
33.5 GMI14­005­DNA (S. aureus)
33.6 GMI14­006­DNA (S. aureus)
Tool for detection of 
MLST:
Tool for detection of 
resistance genes:
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With this survey we seek to capture info in relation to the fastq data set component of the GMI pilot PT. 
 
If you have any questions or feedback for the submission of data via this survey, please contact the PT Coordinator, 
Susanne Karlsmose (suska@food.dtu.dk), at the Technical University of Denmark. 
 
Note: An asterisk (*) indicates a question that requires an answer. 
___________________  
 
GMI is a global, visionary taskforce of scientists and other stakeholders who shares an aim of making novel genomic 
technologies and informatics tools available for improved global patient diagnostics, surveillance and research, by 
developing needs­ and end­user­based data exchange and analysis tools for characterization of all microbial  
organisms and microbial communities. 
 
 
 
1. Institute name / Organization name 
2. Department name
3. Name(s) of person(s) responsible for the analysis
4. Were reads quality filtered before conducting the analysis?  
(please select one answer) 
5. If reads were quality filtered, please provide the name of the program
 
6. For the assembly of the contigs, which tool did you apply?  
In the text box below, please insert name and URL (e.g. Velvet, 
https://www.ebi.ac.uk/~zerbino/velvet/) 
 
7. What kind of methodology for phylogeny construction did you apply?
 
Introduction
*
*
*
 
FASTQ data set
*
Yes
 
nmlkj
No
 
nmlkj
SNPs
 
nmlkj
Methodology other than SNPs
 
nmlkj
If methodology other than SNPs (please specify): 
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If applying SNPs, go to question 8,  
If not applying SNPs, go to question 11 
8. Which reference genome did you use for SNP calling? If you used a reference­free 
approach, please indicate 'none'.
9. Which quality criteria did you use for SNP calling? (e.g. % of mapped reads and 
minimum coverage to define variant).
10. Which criteria did you use for SNPs filtering:
11. Which program did you use to build your tree (e.g., MEGA, MrBayes, PAUP*, GARLI, 
RAxML, etc)? 
 
12. Which algorithm did you use to build your tree (e.g., Neighbor­joining, UPGMA, 
Bayesian, maximum­likelihood, etc)? 
 
Please upload to the ftp­site your DNA sequence matrix as a fasta alignment file, and, if relevant, the distance matrix file (as also described in 
the protocol) 
13. Do you calculate the number of contigs (please select one answer) 
14. Do you filter out contigs below a certain size (please select one answer) 
7.1 ­ S. Typhimurium
7.2 ­ E. coli
7.3 ­ S. aureus
8.1 ­ S. Typhimurium
8.2 ­ E. coli
8.3 ­ S. aureus
9.1 ­ Filter SNPs with excess coverage (i.e. 
repetitive regions):
9.2 ­ Did you filter SNPs occurring in a 
cluster (a.k.a. pruning) (indicate 'yes' or 'no'):
9.3 ­ Which definition of the cluster did you 
use (i.e. ≥3 SNPs in 1000 base pairs (bp):
9.4 ­ Other, please specify:
Yes
 
nmlkj
No
 
nmlkj
Yes
 
nmlkj
No
 
nmlkj
If yes, indicate minimum size 
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15. Do you calculate N50 (please select one answer) 
16. Do you calculate N50 before or after contig size filtering? (please select one answer) 
17. Do you calculate the size of the chromosome (please select one answer) 
18. Do you calculate coverage (please select one answer) 
19. If you calculate coverage, describe how you estimated genome size 
 
As also described in the protocol, please upload to the ftp­site a file containing a table listing the coverage found for each of the 20, 21, 24 
sequences of S. Typhimurium, E. coli and S. aureus. List the code of the strain followed by the obtained coverage. 
Also, please upload a file containing a table listing the number of bases you sequenced for each of the 20, 21, 24 sequences of S. 
Typhimurium, E. coli and S. aureus. List the code of the strain followed the number of bases you sequenced. 
20. For verification of species, which tool did you apply?  
In the text box below, please insert name and URL (e.g. KmerFinder 1.2, 
http://cge.cbs.dtu.dk/services/KmerFinder) 
 
21. Could you verify the species? 
Yes
 
nmlkj
No
 
nmlkj
Before
 
nmlkj
After
 
nmlkj
No filtering
 
nmlkj
Yes
 
nmlkj
No
 
nmlkj
Yes
 
nmlkj
No
 
nmlkj
We did not attempt to verify species
 
nmlkj
Yes, for all S. Typhimurium
 
nmlkj
Yes, for all E. coli
 
nmlkj
Yes, for all S. aureus
 
nmlkj
No, for some S. Typhimurium
 
nmlkj
No, for some E. coli
 
nmlkj
No, for some S. aureus
 
nmlkj
If no, please indicate why 
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22. Can you call a Multi Locus Seqeunce Type (MLST) (please select one answer) 
23. Please describe/interpretation the tree that you obtained based on the following 
questions; 1) How does the analysis indicate that the isolates are linked? 2) How many 
clusters could be identified? 3) How could the clusters be defined?
S. Typhimurium
E. coli
S. aureus
Yes
 
nmlkj
No
 
nmlkj
We are not interested in MLST
 
nmlkj
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GMI proficiency test pilot, 2014 
 
Id: [Id] 
[Name] 
[Name of institute/organization] 
[Country] 
Kgs. Lyngby, Denmark, June 2014 
Dear [Name], 
 
Please find enclosed the bacterial cultures and DNA for the GMI proficiency test pilot, 2014. The bacterial 
strains are shipped lyophilised as KwikStik’s (see further information in the protocol). On arrival, they must 
be refrigerated until handling in the laboratory. The bacterial DNA is shipped as dried samples using a DNA 
stabilizing agent (DNAstable® Plus, Biomatrica). On arrival, either rehydrate your sample and store the 
liquid samples at room temperature in closed tubes, to prevent evaporation. Or store the dried samples in 
either (a) a dry storage cabinet at room temperature (15-25°C or 59-77°F) or (b) a heat-sealed, moisture-
barrier bag along with a silica gel desiccant pack. 
The following documents and information relevant for the GMI proficiency test pilot are available on the 
GMI website (see http://www.globalmicrobialidentifier.org/Workgroups/About-the-GMI-Proficiency-Test-
Pilot-2014): 
- Protocol for GMI pilot proficiency test 2014 
- Link to SurveyMonkey – submission of results for bacterial cultures and DNA  
- Link to SurveyMonkey – submission of results for FASTQ data sets 
 
In the protocol, you will find detailed description for testing the bacterial cultures (item 1a), the 
corresponding DNA (item 1b), and the analysis of the provided datasets. Additionally, you will find 
instructions for submission of results and sequences. To access the ftp-server to/from which sequence 
information can be up- and downloaded, you need the username and password listed below.  
 
Results must be submitted electronically no later than 15 August 2014 
 
.Please acknowledge receipt of this parcel immediately upon arrival. (see enclosed ‘Confirmation Form’).  
 
Do not hesitate to contact us for further information,  
 
Susanne Karlsmose 
EQAS-Coordinator 
 
 
For upload: 
Your username:[user_upload]  
Your password: [password_upload] 
 
For download: 
Your username: [user_download] 
Your password: [password_download]  
 
Please keep this document 
Your usernames and passwords will not appear in other documents 
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Descriptions of how clusters were defined as part of the Dry lab component 
S. Typhimurium 
1) S2 and S12 are closely related to each other. The remaining strains are closely related 
to each other, except S8 (which is further away from S2&S12 than from the other strains 
but seems to still be only distantly related to the other strains)  2) 2 clusters. 3) Cluster 
identification via intra- and intercluster distances using CTree 
(http://www.phylogenetictrees.com/ctree.php) 
1) There is a breadth of diversity among isolates; 2) there is one large cluster with 
possible two other isolates forming a smaller cluster; 3) clusters were defined on relative 
SNP differences among isolates 
Three clusters of closely related isolates, one with 2 isolates, one with 4 isolates that 
included the reference (LT2) 
3 clusters, 2 closely related clusters, then 1 distantly related cluster 
Isolates from the fastq dataset formed three clusters. One cluster contained 15 isolates, 14 
of which were extremely closely related, indicating they could be part of an outbreak. 
The second four-isolate cluster contained 2 subsets each containing a pair of closely 
related isolates. Isolate FSW0035_S11 did not cluster with any of the other isolates. 
1) Well supported clades with small snp distance. 2) 3 clusters. 3) Well supported distinct 
clades with 0 to 39 interstrain snp distance 
1) based on bootstrap 2) 6 clusters 3) based on phylogenetic analysis, MLST and 
resistance genes 
 
 E. coli 
1) S1 and S10 are closely related to each other. The remaining strains are closely related 
to each other. 2) 2 clusters. 3) Cluster identification via intra- and intercluster distances 
using CTree (http://www.phylogenetictrees.com/ctree.php) 
1) there is a breadth of diversity among isolates; 2) in terms of foodborne outbreak 
analysis, there only appear to be two samples that would be considered linked; 3) clusters 
were defined on relative SNP differences among isolates 
two clusters one with two isolates, and the rest belonging to a single cluster with 40 or 
fewer SNPs differentiating the strains 
2 distantly related isolates and 1 main cluster of closely related isolates 
Because we included the isolate 004_E. coli that we sequenced in part one, the resolution 
of the tree was low, so although we could detect three distinct clusters we could not infer 
the relationships of strains within the clusters 
1) Well supported clades with small snp distance. 2) 4 clusters. 3) Well supported distinct 
clades with 1 to 63 interstrain snp distance 
1) based on bootstrap 2) 5 clusters 3) based on phylogenetic analysis, MLST and 
resistance genes 
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S. aureus 
1) Closely related to each other: (M_S5,M_S9), 
(H_S8,M_S3,H_S5,H_S9,H_S10,H_S7,H_S4,H_S6,H_S12,H_S2,H_S1), 
(M_S12,M_S7,M_S4,M_S1,M_S18,M_S11), (M_S3,M_S6),(M_S11),(H_S15),(H_S11). 
2) 6 clusters. 3) Cluster identification via intra- and intercluster distances using CTree 
(http://www.phylogenetictrees.com/ctree.php) 
1) there is a breadth of diversity among isolates; 2) one large cluster likely exists perhaps 
with a second smaller one with about nine samples not belonging to any cluster; 3) 
clusters were defined on relative SNP differences among isolates 
three clusters, one distantly related isolate that clustered with the reference, then one 
cluster of isolates with less then 3 SNPs differentiating the strains, and a second more 
diverse cluster with less then 610 SNP differentiating the isolates, this more diverse 
cluster included three identical isolates 
2 main clusters with 1 group of closely related isolates in one of the clusters 
Isolates were divided into two distinct groups, one containing eight isolates and the other 
containing 16. The latter group contained a cluster of 11 very closely related isolates that 
could belong to a single outbreak, the five other isolates in this group all distinct and 
likely to represent un-linked cases. The group containing eight isolates forms two distinct 
sub-clusters. 
1) Well supported clades with small snp distance. 2) 3 clusters. 3) Well supported distinct 
clades with 0 to 6 interstrain snp distance 
1) based on bootstrap 2) 4 clusters 3) based on phylogenetic analysis, MLST and 
resistance genes 
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